<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Hereditary hemorrhagic telangiectasia - Wikipedia, the free encyclopedia</title>
<meta name="generator" content="MediaWiki 1.26wmf13" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Hereditary_hemorrhagic_telangiectasia" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Hereditary_hemorrhagic_telangiectasia&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Hereditary_hemorrhagic_telangiectasia&amp;action=edit" />
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="alternate" hreflang="x-default" href="/wiki/Hereditary_hemorrhagic_telangiectasia" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="https://en.wikipedia.org/wiki/Hereditary_hemorrhagic_telangiectasia" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cext.wikihiero%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.sectionAnchor%7Cmediawiki.skinning.interface%7Cmediawiki.ui.button%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: global:resourceloader:filter:minify-css:7:de1ab5287c9076b96eedd3f97a84a7b6 */</style>
<script src="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Hereditary_hemorrhagic_telangiectasia","wgTitle":"Hereditary hemorrhagic telangiectasia","wgCurRevisionId":670374599,"wgRevisionId":670374599,"wgArticleId":728467,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["CS1 maint: Explicit use of et al.","Articles with contributors link","Articles that use a Medicine navs subtemplate","Good articles","Diseases of arteries, arterioles and capillaries","Vascular-related cutaneous conditions","Respiratory diseases","Neurological disorders","Autosomal dominant disorders","Cell surface receptor deficiencies"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Hereditary_hemorrhagic_telangiectasia","wgRelevantArticleId":728467,"wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wikilove-recipient":"","wikilove-anon":0,"wgPoweredByHHVM":true,"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","usePageImages":true,"usePageDescriptions":true},"wgGatherShouldShowTutorial":true,"wgGatherPageImageThumbnail":"//upload.wikimedia.org/wikipedia/commons/thumb/2/2d/Case_115.jpg/100px-Case_115.jpg","wgULSAcceptLanguageList":["en-us"],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgWikibaseItemId":"Q776881"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function($,jQuery){mw.user.options.set({"variant":"en"});});
/* cache key: global:resourceloader:filter:minify-js:7:b2706269305541eba923c165462b22c4 */
}</script>
<script>if(window.mw){
mw.loader.implement("user.tokens",function($,jQuery){mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\"});});
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","mmv.head","ext.imageMetrics.head","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static/1.26wmf13/skins/Vector/csshover.min.htc")}</style><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Hereditary_hemorrhagic_telangiectasia skin-vector action-view">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>

							<div id="siteNotice"><!-- CentralNotice --></div>
						<div class="mw-indicators">
<div id="mw-indicator-good-star" class="mw-indicator"><a href="/wiki/Wikipedia:Good_articles" title="This is a good article. Click here for more information."><img alt="This is a good article. Click here for more information." src="//upload.wikimedia.org/wikipedia/en/thumb/9/94/Symbol_support_vote.svg/19px-Symbol_support_vote.svg.png" width="19" height="20" srcset="//upload.wikimedia.org/wikipedia/en/thumb/9/94/Symbol_support_vote.svg/29px-Symbol_support_vote.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/94/Symbol_support_vote.svg/39px-Symbol_support_vote.svg.png 2x" data-file-width="180" data-file-height="185" /></a></div>
</div>
			<h1 id="firstHeading" class="firstHeading" lang="en">Hereditary hemorrhagic telangiectasia</h1>
									<div id="bodyContent" class="mw-body-content">
									<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><table class="infobox" style="width:22em">
<tr>
<th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background-color: lightgrey">Hereditary hemorrhagic telangiectasia</th>
</tr>
<tr>
<td colspan="2" style="text-align:center"><a href="/wiki/File:Case_115.jpg" class="image"><img alt="Case 115.jpg" src="//upload.wikimedia.org/wikipedia/commons/thumb/2/2d/Case_115.jpg/230px-Case_115.jpg" width="230" height="154" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/2/2d/Case_115.jpg/345px-Case_115.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/2d/Case_115.jpg/460px-Case_115.jpg 2x" data-file-width="728" data-file-height="487" /></a>
<div>Characteristic lip telangiectases.</div>
</td>
</tr>
<tr>
<th colspan="2" style="text-align:center">Classification and external resources</th>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></th>
<td><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2015/en#/I78.0">I78.0</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9-CM</a></th>
<td><a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=448.0">448.0</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/OMIM" title="OMIM" class="mw-redirect">OMIM</a></th>
<td><a rel="nofollow" class="external text" href="http://omim.org/entry/187300">187300</a> <a rel="nofollow" class="external text" href="//omim.org/entry/600376">600376</a> <a rel="nofollow" class="external text" href="//omim.org/entry/601101">601101</a> <a rel="nofollow" class="external text" href="//omim.org/entry/610655">610655</a> <a rel="nofollow" class="external text" href="//omim.org/entry/175050">175050</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a rel="nofollow" class="external text" href="http://www.diseasesdatabase.com/ddb9303.htm">9303</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><a rel="nofollow" class="external text" href="http://www.nlm.nih.gov/medlineplus/ency/article/000837.htm">000837</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a rel="nofollow" class="external text" href="http://www.emedicine.com/med/topic2764.htm">med/2764</a> <a rel="nofollow" class="external text" href="http://www.emedicine.com/ped/topic1668.htm#">ped/1668</a> <a rel="nofollow" class="external text" href="http://www.emedicine.com/derm/topic782.htm#">derm/782</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></th>
<td><a rel="nofollow" class="external text" href="//www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&amp;term=D013683">D013683</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/GeneReviews" title="GeneReviews">GeneReviews</a></th>
<td class="plainlist">
<ul>
<li><a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/books/NBK1351/">Hereditary Hemorrhagic Telangiectasia</a></li>
</ul>
</td>
</tr>
</table>
<p><b>Hereditary hemorrhagic telangiectasia</b> (HHT), also known as <b>Rendu–Osler–Weber disease</b>, is an autosomal dominant <a href="/wiki/Genetic_disorder" title="Genetic disorder">genetic disorder</a> that leads to abnormal blood vessel formation in the <a href="/wiki/Human_skin" title="Human skin">skin</a>, <a href="/wiki/Mucous_membrane" title="Mucous membrane">mucous membranes</a>, and often in organs such as the <a href="/wiki/Lung" title="Lung">lungs</a>, <a href="/wiki/Liver" title="Liver">liver</a>, and <a href="/wiki/Brain" title="Brain">brain</a>.<sup id="cite_ref-Shovlin_1-0" class="reference"><a href="#cite_note-Shovlin-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-Dupuis_2-0" class="reference"><a href="#cite_note-Dupuis-2"><span>[</span>2<span>]</span></a></sup></p>
<p>It may lead to <a href="/wiki/Epistaxis" title="Epistaxis" class="mw-redirect">nosebleeds</a>, <a href="/wiki/Gastrointestinal_bleeding" title="Gastrointestinal bleeding">acute and chronic digestive tract bleeding</a>, and various problems due to the involvement of other organs. Treatment focuses on reducing bleeding from blood vessel lesions, and sometimes <a href="/wiki/Surgery" title="Surgery">surgery</a> or other targeted interventions to remove <a href="/wiki/Arteriovenous_malformation" title="Arteriovenous malformation">arteriovenous malformations</a> in organs. Chronic bleeding often requires <a href="/wiki/Iron_supplements" title="Iron supplements" class="mw-redirect">iron supplements</a> and sometimes <a href="/wiki/Blood_transfusion" title="Blood transfusion">blood transfusions</a>. HHT is transmitted in an <a href="/wiki/Dominance_(genetics)" title="Dominance (genetics)">autosomal dominant</a> fashion, and occurs in one in 5,000 people.<sup id="cite_ref-Shovlin_1-1" class="reference"><a href="#cite_note-Shovlin-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-Dupuis_2-1" class="reference"><a href="#cite_note-Dupuis-2"><span>[</span>2<span>]</span></a></sup></p>
<p>The disease carries the names of Sir <a href="/wiki/William_Osler" title="William Osler">William Osler</a>, <a href="/wiki/Henri_Jules_Louis_Marie_Rendu" title="Henri Jules Louis Marie Rendu">Henri Jules Louis Marie Rendu</a>, and <a href="/wiki/Frederick_Parkes_Weber" title="Frederick Parkes Weber">Frederick Parkes Weber</a>, who described it in the late 19th and early 20th centuries.<sup id="cite_ref-Fuchizaki_3-0" class="reference"><a href="#cite_note-Fuchizaki-3"><span>[</span>3<span>]</span></a></sup></p>
<p></p>
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Signs_and_symptoms"><span class="tocnumber">1</span> <span class="toctext">Signs and symptoms</span></a>
<ul>
<li class="toclevel-2 tocsection-2"><a href="#Telangiectasias"><span class="tocnumber">1.1</span> <span class="toctext">Telangiectasias</span></a></li>
<li class="toclevel-2 tocsection-3"><a href="#Arteriovenous_malformation"><span class="tocnumber">1.2</span> <span class="toctext">Arteriovenous malformation</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#Other_problems"><span class="tocnumber">1.3</span> <span class="toctext">Other problems</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-5"><a href="#Genetics"><span class="tocnumber">2</span> <span class="toctext">Genetics</span></a></li>
<li class="toclevel-1 tocsection-6"><a href="#Pathophysiology"><span class="tocnumber">3</span> <span class="toctext">Pathophysiology</span></a></li>
<li class="toclevel-1 tocsection-7"><a href="#Diagnosis"><span class="tocnumber">4</span> <span class="toctext">Diagnosis</span></a>
<ul>
<li class="toclevel-2 tocsection-8"><a href="#Telangiectasias_2"><span class="tocnumber">4.1</span> <span class="toctext">Telangiectasias</span></a></li>
<li class="toclevel-2 tocsection-9"><a href="#Arteriovenous_malformations"><span class="tocnumber">4.2</span> <span class="toctext">Arteriovenous malformations</span></a></li>
<li class="toclevel-2 tocsection-10"><a href="#Genetic_testing"><span class="tocnumber">4.3</span> <span class="toctext">Genetic testing</span></a></li>
<li class="toclevel-2 tocsection-11"><a href="#Criteria"><span class="tocnumber">4.4</span> <span class="toctext">Criteria</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-12"><a href="#Treatment"><span class="tocnumber">5</span> <span class="toctext">Treatment</span></a>
<ul>
<li class="toclevel-2 tocsection-13"><a href="#Nosebleeds"><span class="tocnumber">5.1</span> <span class="toctext">Nosebleeds</span></a></li>
<li class="toclevel-2 tocsection-14"><a href="#Skin_and_digestive_tract"><span class="tocnumber">5.2</span> <span class="toctext">Skin and digestive tract</span></a></li>
<li class="toclevel-2 tocsection-15"><a href="#Lung_AVMs"><span class="tocnumber">5.3</span> <span class="toctext">Lung AVMs</span></a></li>
<li class="toclevel-2 tocsection-16"><a href="#Liver_AVMs"><span class="tocnumber">5.4</span> <span class="toctext">Liver AVMs</span></a></li>
<li class="toclevel-2 tocsection-17"><a href="#Brain_AVMs"><span class="tocnumber">5.5</span> <span class="toctext">Brain AVMs</span></a></li>
<li class="toclevel-2 tocsection-18"><a href="#Experimental_treatments"><span class="tocnumber">5.6</span> <span class="toctext">Experimental treatments</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-19"><a href="#Epidemiology"><span class="tocnumber">6</span> <span class="toctext">Epidemiology</span></a></li>
<li class="toclevel-1 tocsection-20"><a href="#History"><span class="tocnumber">7</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1 tocsection-21"><a href="#References"><span class="tocnumber">8</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-22"><a href="#External_links"><span class="tocnumber">9</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
<p></p>
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hereditary_hemorrhagic_telangiectasia&amp;action=edit&amp;section=1" title="Edit section: Signs and symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Telangiectasias">Telangiectasias</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hereditary_hemorrhagic_telangiectasia&amp;action=edit&amp;section=2" title="Edit section: Telangiectasias">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:TongueTelang.JPG" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/77/TongueTelang.JPG/220px-TongueTelang.JPG" width="220" height="146" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/77/TongueTelang.JPG/330px-TongueTelang.JPG 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/77/TongueTelang.JPG/440px-TongueTelang.JPG 2x" data-file-width="729" data-file-height="485" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:TongueTelang.JPG" class="internal" title="Enlarge"></a></div>
Tongue telangiectases as seen in a person with hereditary hemorrhagic telangiectasia</div>
</div>
</div>
<p><a href="/wiki/Telangiectasia" title="Telangiectasia">Telangiectasia</a> (small vascular malformations) may occur in the skin and mucosal linings of the nose and gastrointestinal tract. The most common problem is <a href="/wiki/Epistaxis" title="Epistaxis" class="mw-redirect">nosebleeds</a> (epistaxis), which happen frequently from childhood and affect about 90–95% of people with HHT. Lesions on the skin and in the mouth bleed less often but may be considered cosmetically displeasing; they affect about 80%.<sup id="cite_ref-Shovlin_1-2" class="reference"><a href="#cite_note-Shovlin-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-Dupuis_2-2" class="reference"><a href="#cite_note-Dupuis-2"><span>[</span>2<span>]</span></a></sup> The skin lesions characteristically occur on the <a href="/wiki/Lip" title="Lip">lips</a>, the <a href="/wiki/Human_nose" title="Human nose">nose</a> and the <a href="/wiki/Finger" title="Finger">fingers</a>, and on the skin of the face in sun-exposed areas. They appear suddenly, with the number increasing over time.<sup id="cite_ref-Dupuis_2-3" class="reference"><a href="#cite_note-Dupuis-2"><span>[</span>2<span>]</span></a></sup></p>
<p>About 20% are affected by symptomatic digestive tract lesions, although a higher percentage have lesions that do not cause symptoms. These lesions may bleed intermittently, which is rarely significant enough to be noticed (in the form of <a href="/wiki/Hematemesis" title="Hematemesis">bloody vomiting</a> or <a href="/wiki/Melena" title="Melena">black stool</a>), but can eventually lead to depletion of <a href="/wiki/Iron" title="Iron">iron</a> in the body, resulting in <a href="/wiki/Iron-deficiency_anemia" title="Iron-deficiency anemia">iron-deficiency anemia</a>.<sup id="cite_ref-Shovlin_1-3" class="reference"><a href="#cite_note-Shovlin-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-Dupuis_2-4" class="reference"><a href="#cite_note-Dupuis-2"><span>[</span>2<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Arteriovenous_malformation">Arteriovenous malformation</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hereditary_hemorrhagic_telangiectasia&amp;action=edit&amp;section=3" title="Edit section: Arteriovenous malformation">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:AVM_grossly.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/9/91/AVM_grossly.jpg/220px-AVM_grossly.jpg" width="220" height="147" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/9/91/AVM_grossly.jpg/330px-AVM_grossly.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/91/AVM_grossly.jpg/440px-AVM_grossly.jpg 2x" data-file-width="767" data-file-height="512" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:AVM_grossly.jpg" class="internal" title="Enlarge"></a></div>
A very large arteriovenous malformation in the left hemisphere (on the right in this image) of the brain.</div>
</div>
</div>
<p><a href="/wiki/Arteriovenous_malformation" title="Arteriovenous malformation">Arteriovenous malformation</a> (AVM, larger vascular malformations) occur in larger organs, predominantly the lungs (50%), liver (30–70%) and the <a href="/wiki/Brain" title="Brain">brain</a> (10%), with a very small proportion (&lt;1%) having AVMs in the <a href="/wiki/Spinal_cord" title="Spinal cord">spinal cord</a>.<sup id="cite_ref-Shovlin_1-4" class="reference"><a href="#cite_note-Shovlin-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-Dupuis_2-5" class="reference"><a href="#cite_note-Dupuis-2"><span>[</span>2<span>]</span></a></sup></p>
<p>Vascular malformations in the lungs may cause a number of problems. The lungs normally "filter out" <a href="/wiki/Bacteria" title="Bacteria">bacteria</a> and <a href="/wiki/Thrombus" title="Thrombus">blood clots</a> from the bloodstream; AVMs bypass the capillary network of the lungs and allow these to <a href="/wiki/Embolism" title="Embolism">migrate</a> to the brain, where bacteria may cause a <a href="/wiki/Brain_abscess" title="Brain abscess">brain abscess</a> and blood clots may lead to <a href="/wiki/Stroke" title="Stroke">stroke</a>.<sup id="cite_ref-Shovlin_1-5" class="reference"><a href="#cite_note-Shovlin-1"><span>[</span>1<span>]</span></a></sup> HHT is the most common cause of lung AVMs: out of all people found to have lung AVMs, 70–80% are due to HHT.<sup id="cite_ref-Gossage_4-0" class="reference"><a href="#cite_note-Gossage-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-Faughnan_5-0" class="reference"><a href="#cite_note-Faughnan-5"><span>[</span>5<span>]</span></a></sup> Bleeding from lung AVMs is relatively unusual, but may cause <a href="/wiki/Hemoptysis" title="Hemoptysis">hemoptysis</a> (coughing up blood) or <a href="/wiki/Hemothorax" title="Hemothorax">hemothorax</a> (blood accumulating in the chest cavity).<sup id="cite_ref-Shovlin_1-6" class="reference"><a href="#cite_note-Shovlin-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-Dupuis_2-6" class="reference"><a href="#cite_note-Dupuis-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-Gossage_4-1" class="reference"><a href="#cite_note-Gossage-4"><span>[</span>4<span>]</span></a></sup> Large vascular malformations in the lung allow oxygen-depleted blood from the <a href="/wiki/Right_ventricle" title="Right ventricle" class="mw-redirect">right ventricle</a> to bypass the <a href="/wiki/Pulmonary_alveolus" title="Pulmonary alveolus">alveoli</a>, meaning that this blood does not have an opportunity to absorb fresh oxygen. This may lead to <a href="/wiki/Dyspnea" title="Dyspnea">breathlessness</a>.<sup id="cite_ref-Gossage_4-2" class="reference"><a href="#cite_note-Gossage-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-Faughnan_5-1" class="reference"><a href="#cite_note-Faughnan-5"><span>[</span>5<span>]</span></a></sup> Large AVMs may lead to <a href="/wiki/Platypnea" title="Platypnea">platypnea</a>, difficulty in breathing that is more marked when sitting up compared to lying down; this probably reflects changes in blood flow associated with positioning.<sup id="cite_ref-Gossage_4-3" class="reference"><a href="#cite_note-Gossage-4"><span>[</span>4<span>]</span></a></sup> Very large AVMs cause a marked inability to absorb oxygen, which may be noted by <a href="/wiki/Cyanosis" title="Cyanosis">cyanosis</a> (bluish discoloration of the lips and skin), <a href="/wiki/Nail_clubbing" title="Nail clubbing">clubbing of the fingernails</a> (often encountered in chronically low oxygen levels), and a <a href="/wiki/Bruit" title="Bruit">humming noise</a> over the affected part of the lung detectable by <a href="/wiki/Stethoscope" title="Stethoscope">stethoscope</a>.<sup id="cite_ref-Gossage_4-4" class="reference"><a href="#cite_note-Gossage-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-Faughnan_5-2" class="reference"><a href="#cite_note-Faughnan-5"><span>[</span>5<span>]</span></a></sup></p>
<p>The symptoms produced by AVMs in the liver depend on the type of abnormal connection that they form between blood vessels. If the connection is between <a href="/wiki/Arteries" title="Arteries" class="mw-redirect">arteries</a> and <a href="/wiki/Vein" title="Vein">veins</a>, a large amount of blood bypasses the body's organs, for which the heart compensates by increasing the <a href="/wiki/Cardiac_output" title="Cardiac output">cardiac output</a>. Eventually <a href="/wiki/Congestive_cardiac_failure" title="Congestive cardiac failure" class="mw-redirect">congestive cardiac failure</a> develops ("high-output cardiac failure"), with breathlessness and leg swelling among other problems.<sup id="cite_ref-Shovlin_1-7" class="reference"><a href="#cite_note-Shovlin-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-Buscarini_6-0" class="reference"><a href="#cite_note-Buscarini-6"><span>[</span>6<span>]</span></a></sup> If the AVM creates a connection between the <a href="/wiki/Portal_vein" title="Portal vein" class="mw-redirect">portal vein</a> and the blood vessels of the liver, the result may be <a href="/wiki/Portal_hypertension" title="Portal hypertension">portal hypertension</a> (increased portal vein pressure), in which collateral blood vessels form in the <a href="/wiki/Esophagus" title="Esophagus">esophagus</a> (<a href="/wiki/Esophageal_varices" title="Esophageal varices">esophageal varices</a>), which may bleed violently; furthermore, the increased pressure may give rise to fluid accumulation in the abdominal cavity (<a href="/wiki/Ascites" title="Ascites">ascites</a>). If the flow in the AVM is in the other direction, portal venous blood flows directly into the veins rather than running through the liver; this may lead to <a href="/wiki/Hepatic_encephalopathy" title="Hepatic encephalopathy">hepatic encephalopathy</a> (confusion due to portal waste products irritating the brain). Rarely, the bile ducts are deprived of blood, leading to severe <a href="/wiki/Cholangitis" title="Cholangitis" class="mw-redirect">cholangitis</a> (inflammation of the bile ducts).<sup id="cite_ref-Shovlin_1-8" class="reference"><a href="#cite_note-Shovlin-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-Buscarini_6-1" class="reference"><a href="#cite_note-Buscarini-6"><span>[</span>6<span>]</span></a></sup> Liver AVMs are detectable in over 70% of people with HHT, but only 10% experience problems as a result.<sup id="cite_ref-Dupuis_2-7" class="reference"><a href="#cite_note-Dupuis-2"><span>[</span>2<span>]</span></a></sup></p>
<p>In the brain, AVMs occasionally exert pressure, leading to <a href="/wiki/Headache" title="Headache">headaches</a>. They may also increase the risk of <a href="/wiki/Seizure" title="Seizure" class="mw-redirect">seizures</a>, as would any abnormal tissue in the brain. Finally, hemorrhage from an AVM may lead to <a href="/wiki/Intracerebral_hemorrhage" title="Intracerebral hemorrhage" class="mw-redirect">intracerebral hemorrhage</a> (bleeding into the brain), which causes any of the symptoms of stroke such as weakness in part of the body or difficulty speaking. If the bleeding occurs into the <a href="/wiki/Subarachnoid_space" title="Subarachnoid space">subarachnoid space</a> (<a href="/wiki/Subarachnoid_hemorrhage" title="Subarachnoid hemorrhage">subarachnoid hemorrhage</a>), there is usually a <a href="/wiki/Thunderclap_headache" title="Thunderclap headache">severe, sudden headache</a> and decreased level of consciousness and often weakness in part of the body.<sup id="cite_ref-Shovlin_1-9" class="reference"><a href="#cite_note-Shovlin-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-Dupuis_2-8" class="reference"><a href="#cite_note-Dupuis-2"><span>[</span>2<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Other_problems">Other problems</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hereditary_hemorrhagic_telangiectasia&amp;action=edit&amp;section=4" title="Edit section: Other problems">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>A very small proportion (those affected by <i>SMAD4</i> mutations, see below) have <a href="/wiki/Juvenile_polyposis_syndrome" title="Juvenile polyposis syndrome">multiple benign polyps</a> in the <a href="/wiki/Colon_(anatomy)" title="Colon (anatomy)" class="mw-redirect">large intestine</a>, which may bleed or transform into <a href="/wiki/Colorectal_cancer" title="Colorectal cancer">colorectal cancer</a>. A similarly small proportion experiences <a href="/wiki/Pulmonary_hypertension" title="Pulmonary hypertension">pulmonary hypertension</a>, a state in which the <a href="/wiki/Pulmonary_artery_pressure" title="Pulmonary artery pressure" class="mw-redirect">pressure in the lung arteries</a> is increased, exerting pressure on the <a href="/wiki/Right_ventricle" title="Right ventricle" class="mw-redirect">right side of the heart</a> and causing <a href="/wiki/Peripheral_edema" title="Peripheral edema">peripheral edema</a> (swelling of the legs), <a href="/wiki/Syncope_(medicine)" title="Syncope (medicine)">fainting</a> and attacks of <a href="/wiki/Chest_pain" title="Chest pain">chest pain</a>. It has been observed that the risk of <a href="/wiki/Thrombosis" title="Thrombosis">thrombosis</a> (particularly <a href="/wiki/Venous_thrombosis" title="Venous thrombosis">venous thrombosis</a>, in the form of <a href="/wiki/Deep_vein_thrombosis" title="Deep vein thrombosis">deep vein thrombosis</a> or <a href="/wiki/Pulmonary_embolism" title="Pulmonary embolism">pulmonary embolism</a>) may be increased. There is a suspicion that those with HHT may have a mild <a href="/wiki/Immunodeficiency" title="Immunodeficiency">immunodeficiency</a> and are therefore at a slightly increased risk from infections.<sup id="cite_ref-Shovlin_1-10" class="reference"><a href="#cite_note-Shovlin-1"><span>[</span>1<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Genetics">Genetics</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hereditary_hemorrhagic_telangiectasia&amp;action=edit&amp;section=5" title="Edit section: Genetics">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Autosomal_dominant_-_en.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/4/4e/Autosomal_dominant_-_en.svg/220px-Autosomal_dominant_-_en.svg.png" width="220" height="382" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/4/4e/Autosomal_dominant_-_en.svg/330px-Autosomal_dominant_-_en.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/4e/Autosomal_dominant_-_en.svg/440px-Autosomal_dominant_-_en.svg.png 2x" data-file-width="738" data-file-height="1283" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Autosomal_dominant_-_en.svg" class="internal" title="Enlarge"></a></div>
Hereditary hemorrhagic telangiectasia has an autosomal dominant pattern of inheritance.</div>
</div>
</div>
<p>HHT is a <a href="/wiki/Genetic_disorder" title="Genetic disorder">genetic disorder</a> by definition. It is inherited in an <a href="/wiki/Autosomal_dominant" title="Autosomal dominant" class="mw-redirect">autosomal dominant</a> manner, which means that an affected person carries one abnormal gene with a 50% chance of passing this gene to offspring. Those with HHT symptoms that have no relatives with the disease may have a new mutation.<sup id="cite_ref-Guideline_7-0" class="reference"><a href="#cite_note-Guideline-7"><span>[</span>7<span>]</span></a></sup> It seems that carrying two abnormal copies of the gene is not compatible with life, and hence no homozygotes have been described.<sup id="cite_ref-Shovlin_1-11" class="reference"><a href="#cite_note-Shovlin-1"><span>[</span>1<span>]</span></a></sup></p>
<p>Five genetic types of HHT are recognized. Of these, three have been <a href="/wiki/Genetic_linkage" title="Genetic linkage">linked</a> to particular <a href="/wiki/Gene" title="Gene">genes</a>, while the two remaining have currently only been associated with a particular <a href="/wiki/Locus_(genetics)" title="Locus (genetics)">locus</a>. More than 80% of all cases of HHT are due to mutations in either <i>ENG</i> or <i>ACVRL1</i>.<sup id="cite_ref-Abdalla_8-0" class="reference"><a href="#cite_note-Abdalla-8"><span>[</span>8<span>]</span></a></sup> A total of over 600 different mutations is known. There is likely to be a predominance of either type in particular populations, but the data are conflicting. <i>MADH4</i> mutations, which cause colonic polyposis in addition to HHT, comprise about 2% of disease-causing mutations. Apart from <i>MADH4</i>, it is not clear whether mutations in <i>ENG</i> and <i>ACVRL1</i> lead to particular symptoms,<sup id="cite_ref-Shovlin_1-12" class="reference"><a href="#cite_note-Shovlin-1"><span>[</span>1<span>]</span></a></sup> although some reports suggest that <i>ENG</i> mutations are more likely to cause lung problems while <i>ACVRL1</i> mutations may cause more liver problems,<sup id="cite_ref-Dupuis_2-9" class="reference"><a href="#cite_note-Dupuis-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-Faughnan_5-3" class="reference"><a href="#cite_note-Faughnan-5"><span>[</span>5<span>]</span></a></sup> and pulmonary hypertension may be a particular problem in people with <i>ACVRL1</i> mutations.<sup id="cite_ref-Abdalla_8-1" class="reference"><a href="#cite_note-Abdalla-8"><span>[</span>8<span>]</span></a></sup> People with exactly the same mutations may have different nature and severity of symptoms, suggesting that additional genes or other risk factors may determine the rate at which lesions develop; these have not yet been identified.<sup id="cite_ref-Dupuis_2-10" class="reference"><a href="#cite_note-Dupuis-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-Abdalla_8-2" class="reference"><a href="#cite_note-Abdalla-8"><span>[</span>8<span>]</span></a></sup></p>
<table class="wikitable">
<tr>
<th>Name</th>
<th><a href="/wiki/OMIM" title="OMIM" class="mw-redirect">OMIM</a></th>
<th>Gene</th>
<th>Locus</th>
<th>Description</th>
</tr>
<tr>
<td>HHT1</td>
<td><a rel="nofollow" class="external text" href="//omim.org/entry/187300">187300</a></td>
<td><i><a href="/wiki/Endoglin" title="Endoglin">ENG</a></i></td>
<td><a href="/wiki/Chromosome_9" title="Chromosome 9" class="mw-redirect">9</a><a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/Omim/getmap.cgi?chromosome=9q34.1">q34.1</a></td>
<td><i>ENG</i> codes for endoglin, a <a href="/wiki/Receptor_(biochemistry)" title="Receptor (biochemistry)">receptor</a> of <a href="/wiki/TGF_beta_1" title="TGF beta 1">TGF-β1</a> (<i>transforming growth factor beta 1</i>) and <a href="/wiki/TGF_beta_3" title="TGF beta 3">TGF-β3</a>; the genetic linkage was identified in 1994.<sup id="cite_ref-McAllister1994_9-0" class="reference"><a href="#cite_note-McAllister1994-9"><span>[</span>9<span>]</span></a></sup> A high proportion of <a href="/wiki/Frameshift_mutation" title="Frameshift mutation">frameshift mutations</a> has been observed.<sup id="cite_ref-Shovlin_1-13" class="reference"><a href="#cite_note-Shovlin-1"><span>[</span>1<span>]</span></a></sup> Practically all mutations occur in the extracellular part of the protein (the part that sits on the <a href="/wiki/Cell_membrane" title="Cell membrane">surface of the cell</a>).<sup id="cite_ref-Abdalla_8-3" class="reference"><a href="#cite_note-Abdalla-8"><span>[</span>8<span>]</span></a></sup></td>
</tr>
<tr>
<td>HHT2</td>
<td><a rel="nofollow" class="external text" href="//omim.org/entry/600376">600376</a></td>
<td><i><a href="/wiki/ACVRL1" title="ACVRL1">ACVRL1</a></i></td>
<td><a href="/wiki/Chromosome_12" title="Chromosome 12" class="mw-redirect">12</a><a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/Omim/getmap.cgi?chromosome=12q11">q11-q14</a></td>
<td><i>ACVRL1</i> codes for Alk-1 (activin receptor-like kinase 1), a TGF-β1 receptor; genetic linkage was identified in 1996.<sup id="cite_ref-Johnson1996_10-0" class="reference"><a href="#cite_note-Johnson1996-10"><span>[</span>10<span>]</span></a></sup></td>
</tr>
<tr>
<td>HHT3</td>
<td><a rel="nofollow" class="external text" href="//omim.org/entry/601101">601101</a></td>
<td><i>Unknown</i></td>
<td><a href="/wiki/Chromosome_5" title="Chromosome 5" class="mw-redirect">5</a><a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/Omim/getmap.cgi?chromosome=5q31">q31</a></td>
<td>Function unknown, linkage identified in 2005.<sup id="cite_ref-11" class="reference"><a href="#cite_note-11"><span>[</span>11<span>]</span></a></sup></td>
</tr>
<tr>
<td>HHT4</td>
<td><a rel="nofollow" class="external text" href="//omim.org/entry/610655">610655</a></td>
<td><i>Unknown</i></td>
<td><a href="/wiki/Chromosome_7" title="Chromosome 7" class="mw-redirect">7</a><a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/Omim/getmap.cgi?chromosome=7p14">p14</a>.</td>
<td>Function unknown, linkage identified in 2006.<sup id="cite_ref-12" class="reference"><a href="#cite_note-12"><span>[</span>12<span>]</span></a></sup></td>
</tr>
<tr>
<td>JPHT</td>
<td><a rel="nofollow" class="external text" href="//omim.org/entry/175050">175050</a></td>
<td><i><a href="/wiki/Mothers_against_decapentaplegic_homolog_4" title="Mothers against decapentaplegic homolog 4">MADH4</a></i></td>
<td><a href="/wiki/Chromosome_18" title="Chromosome 18" class="mw-redirect">18</a><a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/Omim/getmap.cgi?chromosome=18q21">q21.1</a></td>
<td><i>MADH4</i> codes for SMAD4, an intracellular signalling protein for the TGF superfamily receptors. Mutations in this gene cause HHT and juvenile polyposis. Linkage was identified in 2004.<sup id="cite_ref-13" class="reference"><a href="#cite_note-13"><span>[</span>13<span>]</span></a></sup> Mutations mostly in exons 8–11, often <i>de novo</i> (newly acquired, not inherited).<sup id="cite_ref-Shovlin_1-14" class="reference"><a href="#cite_note-Shovlin-1"><span>[</span>1<span>]</span></a></sup></td>
</tr>
</table>
<h2><span class="mw-headline" id="Pathophysiology">Pathophysiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hereditary_hemorrhagic_telangiectasia&amp;action=edit&amp;section=6" title="Edit section: Pathophysiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Endoglin_and_Alk1.png" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/f/f7/Endoglin_and_Alk1.png/220px-Endoglin_and_Alk1.png" width="220" height="145" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/f7/Endoglin_and_Alk1.png/330px-Endoglin_and_Alk1.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/f7/Endoglin_and_Alk1.png/440px-Endoglin_and_Alk1.png 2x" data-file-width="445" data-file-height="293" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Endoglin_and_Alk1.png" class="internal" title="Enlarge"></a></div>
A schematic representation of the TGF-β signaling pathway. Endoglin (yellow) is needed for signalling. The ligand (blue) binds to the receptor complex; red indicates a type II receptor protein, which activates a type I receptor protein (turquiose) such as alk-1, which in turn phosphorylates a SMAD-based nuclear transcription factor (green and purple).</div>
</div>
</div>
<p>Telangiectasias and arteriovenous malformations in HHT are thought to arise because of changes in <a href="/wiki/Angiogenesis" title="Angiogenesis">angiogenesis</a>, the development of blood vessels out of existing ones. The development of a new blood vessel requires the activation and migration of various types of cells, chiefly <a href="/wiki/Endothelium" title="Endothelium">endothelium</a>, <a href="/wiki/Smooth_muscle" title="Smooth muscle" class="mw-redirect">smooth muscle</a> and <a href="/wiki/Pericyte" title="Pericyte">pericytes</a>. The exact mechanism by which the HHT mutations influence this process is not yet clear, and it is likely that they disrupt a balance between pro- and antiangiogenic signals in blood vessels. The wall of telangiectasias is unusually <a href="/wiki/Friable" title="Friable" class="mw-redirect">friable</a>, which explains the tendency of these lesions to bleed.<sup id="cite_ref-Shovlin_1-15" class="reference"><a href="#cite_note-Shovlin-1"><span>[</span>1<span>]</span></a></sup></p>
<p>All genes known so far to be linked to HHT code for proteins in the <a href="/wiki/TGF_beta_signaling_pathway" title="TGF beta signaling pathway">TGF-β signaling pathway</a>. This is a group of proteins that participates in <a href="/wiki/Signal_transduction" title="Signal transduction">signal transduction</a> of hormones of the <a href="/wiki/Transforming_growth_factor_beta_superfamily" title="Transforming growth factor beta superfamily">transforming growth factor beta superfamily</a> (the <a href="/wiki/Transforming_growth_factor_beta" title="Transforming growth factor beta">transforming growth factor beta</a>, <a href="/wiki/Bone_morphogenetic_protein" title="Bone morphogenetic protein">bone morphogenetic protein</a> and <a href="/wiki/Growth_differentiation_factor" title="Growth differentiation factor">growth differentiation factor</a> classes), specifically <a href="/wiki/GDF2" title="GDF2">BMP9/GDF2</a> and <a href="/wiki/Bone_morphogenetic_protein_10" title="Bone morphogenetic protein 10">BMP10</a>. The hormones do not enter the cell but link to receptors on the cell membrane; these then activate other proteins, eventually influencing cellular behavior in a number of ways such as cellular survival, proliferation (increasing in number) and differentiation (becoming more specialized).<sup id="cite_ref-Shovlin_1-16" class="reference"><a href="#cite_note-Shovlin-1"><span>[</span>1<span>]</span></a></sup> For the hormone signal to be adequately transduced, a combination of proteins is needed: two each of two types of <a href="/wiki/Serine/threonine-specific_protein_kinase" title="Serine/threonine-specific protein kinase">serine/threonine-specific kinase type</a> <a href="/wiki/Membrane_receptor" title="Membrane receptor" class="mw-redirect">membrane receptors</a> and endoglin. When bound to the hormone, the type II receptor proteins <a href="/wiki/Phosphorylation" title="Phosphorylation">phosphorylate</a> (transfer <a href="/wiki/Phosphate" title="Phosphate">phosphate</a>) onto type I receptor proteins (of which Alk-1 is one), which in turn phosphorylate a complex of <a href="/wiki/SMAD_(protein)" title="SMAD (protein)">SMAD proteins</a> (chiefly <a href="/wiki/Mothers_against_decapentaplegic_homolog_1" title="Mothers against decapentaplegic homolog 1">SMAD1</a>, <a href="/wiki/Mothers_against_decapentaplegic_homolog_5" title="Mothers against decapentaplegic homolog 5">SMAD5</a> and <a href="/wiki/Mothers_against_decapentaplegic_homolog_9" title="Mothers against decapentaplegic homolog 9">SMAD8</a>). These bind to SMAD4 and migrate to the <a href="/wiki/Cell_nucleus" title="Cell nucleus">cell nucleus</a> where they act as <a href="/wiki/Transcription_factors" title="Transcription factors" class="mw-redirect">transcription factors</a> and participate in the <a href="/wiki/Transcription_(genetics)" title="Transcription (genetics)">transcription</a> of particular genes. In addition to the SMAD pathway, the membrane receptors also act on the <a href="/wiki/MAPK/ERK_pathway" title="MAPK/ERK pathway">MAPK pathway</a>, which has additional actions on the behavior of cells.<sup id="cite_ref-Dupuis_2-11" class="reference"><a href="#cite_note-Dupuis-2"><span>[</span>2<span>]</span></a></sup> Both Alk-1 and endoglin are <a href="/wiki/Gene_expression" title="Gene expression">expressed</a> predominantly in endothelium, perhaps explaining why HHT-causing mutations in these proteins lead predominantly to blood vessel problems.<sup id="cite_ref-Dupuis_2-12" class="reference"><a href="#cite_note-Dupuis-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-Abdalla_8-4" class="reference"><a href="#cite_note-Abdalla-8"><span>[</span>8<span>]</span></a></sup> Both <i>ENG</i> and <i>ACVRL1</i> mutations lead predominantly to underproduction of the related proteins, rather than misfunctioning of the proteins.<sup id="cite_ref-Abdalla_8-5" class="reference"><a href="#cite_note-Abdalla-8"><span>[</span>8<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hereditary_hemorrhagic_telangiectasia&amp;action=edit&amp;section=7" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Diagnostic tests may be conducted for various reasons. Firstly, some tests are needed to confirm or refute the diagnosis. Secondly, some are needed to identify any potential complications.<sup id="cite_ref-Guideline_7-1" class="reference"><a href="#cite_note-Guideline-7"><span>[</span>7<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Telangiectasias_2">Telangiectasias</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hereditary_hemorrhagic_telangiectasia&amp;action=edit&amp;section=8" title="Edit section: Telangiectasias">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Argon_plasma_coagulation.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/a/a5/Argon_plasma_coagulation.jpg/220px-Argon_plasma_coagulation.jpg" width="220" height="212" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/a/a5/Argon_plasma_coagulation.jpg/330px-Argon_plasma_coagulation.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/a5/Argon_plasma_coagulation.jpg/440px-Argon_plasma_coagulation.jpg 2x" data-file-width="441" data-file-height="424" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Argon_plasma_coagulation.jpg" class="internal" title="Enlarge"></a></div>
A vascular lesion in the digestive tract, being treated with argon plasma coagulation.</div>
</div>
</div>
<p>The skin and oral cavity telangiectasias are visually identifiable on <a href="/wiki/Physical_examination" title="Physical examination">physical examination</a>, and similarly the lesions in the nose may be seen on <a href="/wiki/Endoscopy" title="Endoscopy">endoscopy</a> of the <a href="/wiki/Nasopharynx" title="Nasopharynx" class="mw-redirect">nasopharynx</a> or on <a href="/wiki/Laryngoscope" title="Laryngoscope" class="mw-redirect">laryngoscopy</a>. The severity of nosebleeds may be quantified objectively using a grid-like questionnaire in which the number of nosebleed episodes and their duration is recorded.<sup id="cite_ref-Dupuis_2-13" class="reference"><a href="#cite_note-Dupuis-2"><span>[</span>2<span>]</span></a></sup></p>
<p>Digestive tract telangiectasias may be identified on <a href="/wiki/Esophagogastroduodenoscopy" title="Esophagogastroduodenoscopy">esophagogastroduodenoscopy</a> (endoscopy of the esophagus, stomach and first part of the small intestine). This procedure will typically only be undertaken if there is anemia that is more marked than expected by the severity of nosebleeds, or if there is evidence of severe bleeding (vomiting blood, black stools). If the number of lesions seen on endoscopy is unexpectedly low, the remainder of the small intestine may be examined with <a href="/wiki/Capsule_endoscopy" title="Capsule endoscopy">capsule endoscopy</a>, in which the patient swallows a capsule-shaped device containing a miniature camera which transmits images of the digestive tract to a portable digital recorder.<sup id="cite_ref-Dupuis_2-14" class="reference"><a href="#cite_note-Dupuis-2"><span>[</span>2<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Arteriovenous_malformations">Arteriovenous malformations</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hereditary_hemorrhagic_telangiectasia&amp;action=edit&amp;section=9" title="Edit section: Arteriovenous malformations">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Identification of AVMs requires detailed <a href="/wiki/Medical_imaging" title="Medical imaging">medical imaging</a> of the organs most commonly affected by these lesions. Not all AVMs cause symptoms or are at risk of doing so, and hence there is a degree of variation between specialists as to whether such investigations would be performed, and by which modality; often, decisions on this issue are reached together with the patient.<sup id="cite_ref-Shovlin_1-17" class="reference"><a href="#cite_note-Shovlin-1"><span>[</span>1<span>]</span></a></sup></p>
<p>Lung AVMs may be suspected because of the abnormal appearance of the lungs on a <a href="/wiki/Chest_radiograph" title="Chest radiograph">chest X-ray</a>, or <a href="/wiki/Hypoxia_(medical)" title="Hypoxia (medical)">hypoxia</a> (low oxygen levels) on <a href="/wiki/Pulse_oximetry" title="Pulse oximetry">pulse oximetry</a> or <a href="/wiki/Arterial_blood_gas" title="Arterial blood gas">arterial blood gas</a> determination. <a href="/wiki/Transthoracic_echocardiography" title="Transthoracic echocardiography" class="mw-redirect">Bubble contrast echocardiography</a> (bubble echo) may be used as a screening tool to identify abnormal connections between the <a href="/wiki/Pulmonary_artery" title="Pulmonary artery">lung arteries</a> and <a href="/wiki/Pulmonary_vein" title="Pulmonary vein">veins</a>. This involves the injection of agitated <a href="/wiki/Saline_(medicine)" title="Saline (medicine)">saline</a> into a vein, followed by ultrasound-based imaging of the heart. Normally, the lungs remove small air bubbles from the circulation, and they are therefore only seen in the <a href="/wiki/Right_atrium" title="Right atrium" class="mw-redirect">right atrium</a> and the <a href="/wiki/Right_ventricle" title="Right ventricle" class="mw-redirect">right ventricle</a>. If an AVM is present, bubbles appear in the <a href="/wiki/Left_atrium" title="Left atrium" class="mw-redirect">left atrium</a> and <a href="/wiki/Left_ventricle" title="Left ventricle" class="mw-redirect">left ventricle</a>, usually 3–10 <a href="/wiki/Cardiac_cycle" title="Cardiac cycle">cardiac cycles</a> after the right side; this is slower than in <a href="/wiki/Congenital_heart_defect" title="Congenital heart defect">heart defects</a>, in which there are direct connections between the right and left side of the heart. A larger number of bubbles is more likely to indicate the presence of an AVM. Bubble echo is not a perfect screening tool as it can miss smaller AVMs and does not identify the site of AVMs. Often <a href="/wiki/Radiocontrast" title="Radiocontrast" class="mw-redirect">contrast</a>-enhanced <a href="/wiki/X-ray_computed_tomography" title="X-ray computed tomography" class="mw-redirect">computed tomography</a> (CT angiography) is used to identify lung lesions; this modality has a <a href="/wiki/Sensitivity_and_specificity" title="Sensitivity and specificity">sensitivity</a> of over 90%.<sup id="cite_ref-Shovlin_1-18" class="reference"><a href="#cite_note-Shovlin-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-Dupuis_2-15" class="reference"><a href="#cite_note-Dupuis-2"><span>[</span>2<span>]</span></a></sup> It may be possible to omit contrast administration on modern CT scanners.<sup id="cite_ref-Faughnan_5-4" class="reference"><a href="#cite_note-Faughnan-5"><span>[</span>5<span>]</span></a></sup> Echocardiography is also used if there is a suspicion of pulmonary hypertension or high-output cardiac failure due to large liver lesions, sometimes followed by <a href="/wiki/Cardiac_catheterization" title="Cardiac catheterization">cardiac catheterization</a> to measure the pressures inside the various chambers of the heart.<sup id="cite_ref-Shovlin_1-19" class="reference"><a href="#cite_note-Shovlin-1"><span>[</span>1<span>]</span></a></sup></p>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Morbus-Osler-CT-Leber-ax-010.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b5/Morbus-Osler-CT-Leber-ax-010.jpg/220px-Morbus-Osler-CT-Leber-ax-010.jpg" width="220" height="164" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b5/Morbus-Osler-CT-Leber-ax-010.jpg/330px-Morbus-Osler-CT-Leber-ax-010.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b5/Morbus-Osler-CT-Leber-ax-010.jpg/440px-Morbus-Osler-CT-Leber-ax-010.jpg 2x" data-file-width="512" data-file-height="382" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Morbus-Osler-CT-Leber-ax-010.jpg" class="internal" title="Enlarge"></a></div>
CT-scan of vascular malformations in the liver in a patient with hereditary hemorrhagic telangiectasia causing an inhomogeneous perfusion pattern.</div>
</div>
</div>
<p>Liver AVMs may be suspected because of abnormal <a href="/wiki/Liver_function_tests" title="Liver function tests">liver function tests</a> in the blood, because the symptoms of heart failure develop, or because of <a href="/wiki/Jaundice" title="Jaundice">jaundice</a> or other symptoms of liver dysfunction. The most reliable initial screening test is <a href="/wiki/Medical_ultrasonography#Doppler_sonography" title="Medical ultrasonography" class="mw-redirect">Doppler ultrasonography</a> of the liver; this has a very high sensitivity for identifying vascular lesions in the liver. If necessary, contrast-enhanced CT may be used to further characterize AVMs.<sup id="cite_ref-Shovlin_1-20" class="reference"><a href="#cite_note-Shovlin-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-Dupuis_2-16" class="reference"><a href="#cite_note-Dupuis-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-Buscarini_6-2" class="reference"><a href="#cite_note-Buscarini-6"><span>[</span>6<span>]</span></a></sup> It is extremely common to find incidental nodules on liver scans, most commonly due to <a href="/wiki/Focal_nodular_hyperplasia" title="Focal nodular hyperplasia">focal nodular hyperplasia</a> (FNH), as these are a hundredfold times more common in HHT compared to the general population. FNH is regarded as harmless. Generally, <a href="/wiki/Tumor_marker" title="Tumor marker">tumor markers</a> and additional imaging modalities are used to differentiate between FNH and malignant tumors of the liver. <a href="/wiki/Liver_biopsy" title="Liver biopsy">Liver biopsy</a> is discouraged in people with HHT as the risk of hemorrhage from liver AVMs may be significant.<sup id="cite_ref-Buscarini_6-3" class="reference"><a href="#cite_note-Buscarini-6"><span>[</span>6<span>]</span></a></sup><sup id="cite_ref-Guideline_7-2" class="reference"><a href="#cite_note-Guideline-7"><span>[</span>7<span>]</span></a></sup> Liver scans may be useful if someone is suspected of HHT, but does not meet the criteria (see below) unless liver lesions can be demonstrated.<sup id="cite_ref-Guideline_7-3" class="reference"><a href="#cite_note-Guideline-7"><span>[</span>7<span>]</span></a></sup></p>
<p>Brain AVMs may be detected on <a href="/wiki/Computed_tomography_angiography" title="Computed tomography angiography">computed tomography angiography</a> (CTA or CT angio) or <a href="/wiki/Magnetic_resonance_angiography" title="Magnetic resonance angiography">magnetic resonance angiography</a> (MRA); CTA is better in showing the vessels themselves, and MRA provides more detail about the relationship between an AVM and surrounding brain tissue.<sup id="cite_ref-Friedlander_14-0" class="reference"><a href="#cite_note-Friedlander-14"><span>[</span>14<span>]</span></a></sup> In general, MRI is recommended.<sup id="cite_ref-Dupuis_2-17" class="reference"><a href="#cite_note-Dupuis-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-Guideline_7-4" class="reference"><a href="#cite_note-Guideline-7"><span>[</span>7<span>]</span></a></sup> Various types of vascular malformations may be encountered: AVMs, micro-AVMs, telangiectasias and arteriovenous <a href="/wiki/Fistula" title="Fistula">fistulas</a>.<sup id="cite_ref-Guideline_7-5" class="reference"><a href="#cite_note-Guideline-7"><span>[</span>7<span>]</span></a></sup> If surgery, embolization, or other treatment is contemplated (see below), <a href="/wiki/Cerebral_angiography" title="Cerebral angiography">cerebral angiography</a> may be required to get sufficient detail of the vessels. This procedure carries a small risk of stroke (0.5%) and is therefore limited to specific circumstances.<sup id="cite_ref-Guideline_7-6" class="reference"><a href="#cite_note-Guideline-7"><span>[</span>7<span>]</span></a></sup><sup id="cite_ref-Friedlander_14-1" class="reference"><a href="#cite_note-Friedlander-14"><span>[</span>14<span>]</span></a></sup> Recent professional guidelines recommend that all children with suspected or definite HHT undergo a brain MRI early in life to identify AVMs that can cause major complications.<sup id="cite_ref-Guideline_7-7" class="reference"><a href="#cite_note-Guideline-7"><span>[</span>7<span>]</span></a></sup> Others suggest that screening for cerebral AVMs is probably unnecessary in those who are not experiencing any neurological symptoms, because most lesions discovered on screening scans would not require treatment, creating undesirable conundrums.<sup id="cite_ref-Shovlin_1-21" class="reference"><a href="#cite_note-Shovlin-1"><span>[</span>1<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Genetic_testing">Genetic testing</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hereditary_hemorrhagic_telangiectasia&amp;action=edit&amp;section=10" title="Edit section: Genetic testing">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Genetic tests are available for the <i>ENG</i>, <i>ACVRL1</i> and <i>MADH4</i> mutations. Testing is not always needed for diagnosis, because the symptoms are sufficient to distinguish the disease from other diagnoses. There are situations in which testing can be particularly useful. Firstly, children and young adults with a parent with definite HHT may have limited symptoms, yet be at risk from some of the complications mentioned above; if the mutation is known in the affected parent, absence of this mutation in the child would prevent the need for screening tests. Furthermore, genetic testing may confirm the diagnosis in those with limited symptoms who otherwise would have been labeled "possible HHT" (see below).<sup id="cite_ref-Guideline_7-8" class="reference"><a href="#cite_note-Guideline-7"><span>[</span>7<span>]</span></a></sup></p>
<p>Genetic diagnosis in HHT is difficult, as mutations occur in numerous different locations in the linked genes, without particular mutations being highly frequent (as opposed to, for instance, the <a href="/wiki/%CE%94F508" title="ΔF508">ΔF508</a> mutation in <a href="/wiki/Cystic_fibrosis" title="Cystic fibrosis">cystic fibrosis</a>). <a href="/wiki/Sequence_analysis" title="Sequence analysis">Sequence analysis</a> of the involved genes is therefore the most useful approach (sensitivity 75%), followed by additional testing to detect large deletions and duplications (additional 10%). Not all mutations in these genes have been linked with disease.<sup id="cite_ref-Guideline_7-9" class="reference"><a href="#cite_note-Guideline-7"><span>[</span>7<span>]</span></a></sup></p>
<p>Mutations in the <i>MADH4</i> gene is usually associated with juvenile polyposis, and detection of such a mutation would indicate a need to screen the patient and affected relatives for polyps and tumors of the large intestine.<sup id="cite_ref-Guideline_7-10" class="reference"><a href="#cite_note-Guideline-7"><span>[</span>7<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Criteria">Criteria</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hereditary_hemorrhagic_telangiectasia&amp;action=edit&amp;section=11" title="Edit section: Criteria">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The diagnosis can be made depending on the presence of four criteria, known as the "<a href="/wiki/Cura%C3%A7ao" title="Curaçao">Curaçao</a> criteria".<sup id="cite_ref-Shovlin2000_15-0" class="reference"><a href="#cite_note-Shovlin2000-15"><span>[</span>15<span>]</span></a></sup> If three or four are met, a patient has "definite HHT", while two gives "possible HHT":</p>
<ol>
<li>Spontaneous recurrent <a href="/wiki/Epistaxis" title="Epistaxis" class="mw-redirect">epistaxis</a></li>
<li>Multiple telangiectasias in typical locations (see above)</li>
<li>Proven visceral AVM (lung, liver, brain, spine)</li>
<li>First-degree family member with HHT</li>
</ol>
<p>Despite the designation "possible", someone with a visceral AVM and a family history but no nosebleeds or telangiectasias is still extremely likely to have HHT, because these AVMs are very uncommon in the general population. At the same time, the same cannot be said of nosebleeds and sparse telangiectasias, both of which occur in people without HHT, in the absence of AVMs. Someone's diagnostic status may change in the course of life, as young children may not yet exhibit all the symptoms; at age 16, thirteen percent are still indeterminate, while at age 60 the vast majority (99%) have a definite diagnostic classification. The children of established HHT patients may therefore be labeled as "possible HHT", as 50% may turn out to have HHT in the course of their life.<sup id="cite_ref-Shovlin_1-22" class="reference"><a href="#cite_note-Shovlin-1"><span>[</span>1<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Treatment">Treatment</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hereditary_hemorrhagic_telangiectasia&amp;action=edit&amp;section=12" title="Edit section: Treatment">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Treatment of HHT is <a href="/wiki/Symptomatic_treatment" title="Symptomatic treatment">symptomatic</a> (it deals with the symptoms rather than the disease itself), as there is no therapy that stops the development of telangiectasias and AVMs directly. Furthermore, some treatments are applied to prevent the development of common complications.<sup id="cite_ref-Guideline_7-11" class="reference"><a href="#cite_note-Guideline-7"><span>[</span>7<span>]</span></a></sup> Chronic nosebleeds and digestive tract bleeding can both lead to anemia; if the bleeding itself cannot be completely stopped, the anemia requires treatment with <a href="/wiki/Iron_supplements" title="Iron supplements" class="mw-redirect">iron supplements</a>. Those who cannot tolerate iron tablets or solutions may require administration of <a href="/wiki/Intravenous_therapy" title="Intravenous therapy">intravenous</a> iron sucrose, and <a href="/wiki/Blood_transfusion" title="Blood transfusion">blood transfusion</a> if the anemia is causing severe symptoms that warrant rapid improvement of the blood count.<sup id="cite_ref-Dupuis_2-18" class="reference"><a href="#cite_note-Dupuis-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-Guideline_7-12" class="reference"><a href="#cite_note-Guideline-7"><span>[</span>7<span>]</span></a></sup></p>
<p>Most treatments used in HHT have been described in adults, and the experience in treating children is more limited.<sup id="cite_ref-Guideline_7-13" class="reference"><a href="#cite_note-Guideline-7"><span>[</span>7<span>]</span></a></sup> Women with HHT who get <a href="/wiki/Pregnancy" title="Pregnancy">pregnant</a> are at an increased risk of complications, and are observed closely, although the absolute risk is still low (1%).<sup id="cite_ref-Shovlin_1-23" class="reference"><a href="#cite_note-Shovlin-1"><span>[</span>1<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Nosebleeds">Nosebleeds</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hereditary_hemorrhagic_telangiectasia&amp;action=edit&amp;section=13" title="Edit section: Nosebleeds">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>An acute nosebleed may be managed with a variety of measures, such as packing of the nasal cavity with absorbent swabs or gels. Removal of the packs after the bleeding may lead to reopening of the fragile vessels, and therefore lubricated or atraumatic packing is recommended.<sup id="cite_ref-Guideline_7-14" class="reference"><a href="#cite_note-Guideline-7"><span>[</span>7<span>]</span></a></sup> Some patients may wish to learn packing themselves to deal with nosebleeds without having to resort to medical help.<sup id="cite_ref-Geisthoff_16-0" class="reference"><a href="#cite_note-Geisthoff-16"><span>[</span>16<span>]</span></a></sup></p>
<p>Frequent nosebleeds can be prevented in part by keeping the nostrils moist, and by applying <a href="/wiki/Saline_(medicine)" title="Saline (medicine)">saline solution</a>, <a href="/wiki/Estrogen" title="Estrogen">estrogen</a>-containing creams or <a href="/wiki/Tranexamic_acid" title="Tranexamic acid">tranexamic acid</a>; these have few side effects and may have a small degree of benefit.<sup id="cite_ref-Guideline_7-15" class="reference"><a href="#cite_note-Guideline-7"><span>[</span>7<span>]</span></a></sup> A number of additional modalities has been used to prevent recurrent bleeding if simple measures are unsuccessful. Medical therapies include oral tranexamic acid and estrogen; the <a href="/wiki/Evidence-based_medicine" title="Evidence-based medicine">evidence</a> for these is relatively limited, and estrogen is poorly tolerated by men and possibly carries risks of cancer and heart disease in women past the menopause.<sup id="cite_ref-Dupuis_2-19" class="reference"><a href="#cite_note-Dupuis-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-Guideline_7-16" class="reference"><a href="#cite_note-Guideline-7"><span>[</span>7<span>]</span></a></sup> Nasal coagulation and <a href="/wiki/Cauterization" title="Cauterization">cauterization</a> may reduce the bleeding from telangiectasias, and is recommended before surgery is considered; often, several sessions are needed. It may be possible to <a href="/wiki/Embolization" title="Embolization">embolize</a> vascular lesions through <a href="/wiki/Interventional_radiology" title="Interventional radiology">interventional radiology</a>; this requires passing a catheter through a large artery and locating the <a href="/wiki/Maxillary_artery" title="Maxillary artery">maxillary artery</a> under <a href="/wiki/Fluoroscopy" title="Fluoroscopy">X-ray guidance</a>, followed by the injection into the vessel of particles that occlude the blood vessels. The benefit from the procedure tends to be short-lived,<sup id="cite_ref-Guideline_7-17" class="reference"><a href="#cite_note-Guideline-7"><span>[</span>7<span>]</span></a></sup> and it may be most appropriate in episodes of severe bleeding.<sup id="cite_ref-Geisthoff_16-1" class="reference"><a href="#cite_note-Geisthoff-16"><span>[</span>16<span>]</span></a></sup></p>
<p>If other interventions have failed, several operations have been reported to provide benefit. One is septal dermoplasty or Saunders' procedure,<sup id="cite_ref-17" class="reference"><a href="#cite_note-17"><span>[</span>17<span>]</span></a></sup> in which skin is transplanted into the nostrils, and the other is Young's procedure,<sup id="cite_ref-18" class="reference"><a href="#cite_note-18"><span>[</span>18<span>]</span></a></sup> in which the nostrils are sealed off completely.<sup id="cite_ref-Guideline_7-18" class="reference"><a href="#cite_note-Guideline-7"><span>[</span>7<span>]</span></a></sup><sup id="cite_ref-Geisthoff_16-2" class="reference"><a href="#cite_note-Geisthoff-16"><span>[</span>16<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Skin_and_digestive_tract">Skin and digestive tract</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hereditary_hemorrhagic_telangiectasia&amp;action=edit&amp;section=14" title="Edit section: Skin and digestive tract">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The skin lesions of HHT can be disfiguring, and may respond to treatment with long-pulsed <a href="/wiki/Nd:YAG_laser" title="Nd:YAG laser">Nd:YAG laser</a>.<sup id="cite_ref-Dupuis_2-20" class="reference"><a href="#cite_note-Dupuis-2"><span>[</span>2<span>]</span></a></sup> Skin lesions in the fingertips may sometimes bleed and cause pain. <a href="/wiki/Skin_grafting" title="Skin grafting">Skin grafting</a> is occasionally needed to treat this problem.<sup id="cite_ref-Dupuis_2-21" class="reference"><a href="#cite_note-Dupuis-2"><span>[</span>2<span>]</span></a></sup></p>
<p>With regards to digestive tract lesions, mild bleeding and mild resultant anemia is treated with iron supplementation, and no specific treatment is administered. There is limited data on hormone treatment and tranexamic acid to reduce bleeding and anemia. Severe anemia or episodes of severe bleeding are treated with endoscopic <a href="/wiki/Argon_plasma_coagulation" title="Argon plasma coagulation">argon plasma coagulation</a> (APC) or laser treatment of any lesions identified; this may reduce the need for supportive treatment. The expected benefits are not such that repeated attempts at treating lesions are advocated.<sup id="cite_ref-Guideline_7-19" class="reference"><a href="#cite_note-Guideline-7"><span>[</span>7<span>]</span></a></sup> Sudden, very severe bleeding is unusual—if encountered, alternative causes (such as a <a href="/wiki/Peptic_ulcer" title="Peptic ulcer">peptic ulcer</a>) need to be considered<sup id="cite_ref-Guideline_7-20" class="reference"><a href="#cite_note-Guideline-7"><span>[</span>7<span>]</span></a></sup>—but embolization may be used in such instances.<sup id="cite_ref-Shovlin_1-24" class="reference"><a href="#cite_note-Shovlin-1"><span>[</span>1<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Lung_AVMs">Lung AVMs</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hereditary_hemorrhagic_telangiectasia&amp;action=edit&amp;section=15" title="Edit section: Lung AVMs">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Lung lesions, once identified, are usually treated to prevent episodes of bleeding and more importantly embolism to the brain. This is particularly done in lesions with a feeding blood vessel of 3&#160;mm or larger, as these are the most likely to cause long-term complications unless treated. The most effective current therapy is embolization with detachable metal coils. The procedure involves puncture of a large vein (usually under a <a href="/wiki/General_anaesthetic" title="General anaesthetic">general anesthetic</a>), followed by <a href="/wiki/Cardiac_catheterization" title="Cardiac catheterization">advancing of a catheter through the right ventricle</a> and into the <a href="/wiki/Pulmonary_artery" title="Pulmonary artery">pulmonary artery</a>, after which <a href="/wiki/Radiocontrast" title="Radiocontrast" class="mw-redirect">radiocontrast</a> is injected to visualize the AVMs (<a href="/wiki/Pulmonary_angiography" title="Pulmonary angiography">pulmonary angiography</a>). Once the lesion has been identified, coils are deployed that obstruct the blood flow and allow the lesion to regress. In experienced hands, the procedure tends to be very effective and with limited side effects, but lesions may recur and further attempts may be required. CTA scans are repeated to monitor for recurrence.<sup id="cite_ref-Dupuis_2-22" class="reference"><a href="#cite_note-Dupuis-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-Gossage_4-5" class="reference"><a href="#cite_note-Gossage-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-Faughnan_5-5" class="reference"><a href="#cite_note-Faughnan-5"><span>[</span>5<span>]</span></a></sup><sup id="cite_ref-Guideline_7-21" class="reference"><a href="#cite_note-Guideline-7"><span>[</span>7<span>]</span></a></sup> Surgical excision has now essentially been abandoned due to the success of embolotherapy.<sup id="cite_ref-Faughnan_5-6" class="reference"><a href="#cite_note-Faughnan-5"><span>[</span>5<span>]</span></a></sup><sup id="cite_ref-Guideline_7-22" class="reference"><a href="#cite_note-Guideline-7"><span>[</span>7<span>]</span></a></sup></p>
<p>Those with either definite pulmonary AVMs or an abnormal contrast echocardiogram with no clearly visible lesions are deemed to be at risk from brain emboli. They are therefore counselled to avoid <a href="/wiki/Scuba_diving" title="Scuba diving">scuba diving</a>, during which small air bubbles may form in the bloodsteam that may migrate to the brain and cause stroke. Similarly, <a href="/wiki/Antimicrobial_prophylaxis" title="Antimicrobial prophylaxis" class="mw-redirect">antimicrobial prophylaxis</a> is advised during procedures in which bacteria may enter the bloodstream, such as <a href="/wiki/Dentistry" title="Dentistry">dental work</a>, and avoidance of air bubbles during <a href="/wiki/Intravenous_therapy" title="Intravenous therapy">intravenous therapy</a>.<sup id="cite_ref-Dupuis_2-23" class="reference"><a href="#cite_note-Dupuis-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-Faughnan_5-7" class="reference"><a href="#cite_note-Faughnan-5"><span>[</span>5<span>]</span></a></sup><sup id="cite_ref-Guideline_7-23" class="reference"><a href="#cite_note-Guideline-7"><span>[</span>7<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Liver_AVMs">Liver AVMs</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hereditary_hemorrhagic_telangiectasia&amp;action=edit&amp;section=16" title="Edit section: Liver AVMs">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Given that liver AVMs generally cause high-output cardiac failure, the emphasis is on treating this with <a href="/wiki/Diuretic" title="Diuretic">diuretics</a> to reduce the circulating blood volume, restriction of salt and fluid intake, and <a href="/wiki/Antiarrhythmic_agent" title="Antiarrhythmic agent">antiarrhythmic agents</a> in case of <a href="/wiki/Cardiac_dysrhythmia" title="Cardiac dysrhythmia" class="mw-redirect">irregular heart beat</a>. This may be sufficient in treating the symptoms of swelling and breathlessness. If this treatment is not effective or leads to side effects or complications, the only remaining option is <a href="/wiki/Liver_transplantation" title="Liver transplantation">liver transplantation</a>. This is reserved for those with severe symptoms, as it carries a <a href="/wiki/Mortality_rate" title="Mortality rate">mortality</a> of about 10%, but leads to good results if successful.<sup id="cite_ref-Buscarini_6-4" class="reference"><a href="#cite_note-Buscarini-6"><span>[</span>6<span>]</span></a></sup><sup id="cite_ref-Guideline_7-24" class="reference"><a href="#cite_note-Guideline-7"><span>[</span>7<span>]</span></a></sup> The exact point at which liver transplantion is to be offered is not yet completely established.<sup id="cite_ref-Buscarini_6-5" class="reference"><a href="#cite_note-Buscarini-6"><span>[</span>6<span>]</span></a></sup> Embolization treatment has been attempted, but leads to severe complications in a proportion of patients and is discouraged.<sup id="cite_ref-Faughnan_5-8" class="reference"><a href="#cite_note-Faughnan-5"><span>[</span>5<span>]</span></a></sup><sup id="cite_ref-Buscarini_6-6" class="reference"><a href="#cite_note-Buscarini-6"><span>[</span>6<span>]</span></a></sup><sup id="cite_ref-Guideline_7-25" class="reference"><a href="#cite_note-Guideline-7"><span>[</span>7<span>]</span></a></sup></p>
<p>Other liver-related complications (portal hypertension, esophageal varices, ascites, hepatic encephalopathy) are treated with the same modalities as used in <a href="/wiki/Cirrhosis" title="Cirrhosis">cirrhosis</a>, although the use of <a href="/wiki/Transjugular_intrahepatic_portosystemic_shunt" title="Transjugular intrahepatic portosystemic shunt">transjugular intrahepatic portosystemic shunt</a> treatment is discouraged due to the lack of documented benefit.<sup id="cite_ref-Buscarini_6-7" class="reference"><a href="#cite_note-Buscarini-6"><span>[</span>6<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Brain_AVMs">Brain AVMs</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hereditary_hemorrhagic_telangiectasia&amp;action=edit&amp;section=17" title="Edit section: Brain AVMs">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The decision to treat brain AVMs depends on the symptoms that they cause (such as seizures or headaches). The bleeding risk is predicted by previous episodes of hemorrhage, and whether on the CTA or MRA scan the AVM appears to be deep seated or have deep venous drainage. Size of the AVM and the presence of <a href="/wiki/Aneurysm" title="Aneurysm">aneurysms</a> appears to matter less.<sup id="cite_ref-Friedlander_14-2" class="reference"><a href="#cite_note-Friedlander-14"><span>[</span>14<span>]</span></a></sup> In HHT, some lesions (high-flow arteriovenous fistulae) tend to cause more problems, and treatment is warranted. Other AVMs may regress over time without intervention.<sup id="cite_ref-Guideline_7-26" class="reference"><a href="#cite_note-Guideline-7"><span>[</span>7<span>]</span></a></sup> Various modalities are available, depending on the location of the AVM and its size: surgery, radiation-based treatment and embolization. Sometimes, multiple modalities are used on the same lesion.<sup id="cite_ref-Dupuis_2-24" class="reference"><a href="#cite_note-Dupuis-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-Friedlander_14-3" class="reference"><a href="#cite_note-Friedlander-14"><span>[</span>14<span>]</span></a></sup></p>
<p>Surgery (by <a href="/wiki/Craniotomy" title="Craniotomy">craniotomy</a>, open brain surgery) may be offered based on the risks of treatment as determined by the Spetzler–Martin scale (grade I-V); this score is higher in larger lesions that are close to important brain structures and have deep venous drainage. High grade lesions (IV and V) have an unacceptably high risk and surgery is not typically offered in those cases. <a href="/wiki/Radiosurgery" title="Radiosurgery">Radiosurgery</a> (using targeted <a href="/wiki/Radiation_therapy" title="Radiation therapy">radiation therapy</a> such as by a <a href="/wiki/Gamma_knife" title="Gamma knife" class="mw-redirect">gamma knife</a>) may be used if the lesion is small but close to vital structures. Finally, embolization may be used on small lesions that have only a single feeding vessel.<sup id="cite_ref-Friedlander_14-4" class="reference"><a href="#cite_note-Friedlander-14"><span>[</span>14<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Experimental_treatments">Experimental treatments</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hereditary_hemorrhagic_telangiectasia&amp;action=edit&amp;section=18" title="Edit section: Experimental treatments">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Several anti-<a href="/wiki/Angiogenesis" title="Angiogenesis">angiogenesis</a> drugs approved for other conditions, such as cancer, have been investigated in small clinical trials.<sup id="cite_ref-pmid20870325_19-0" class="reference"><a href="#cite_note-pmid20870325-19"><span>[</span>19<span>]</span></a></sup> The anti-<a href="/wiki/VEGF" title="VEGF" class="mw-redirect">VEGF</a> antibody <a href="/wiki/Bevacizumab" title="Bevacizumab">bevacizumab</a>, for instance, has been used <a href="/wiki/Off-label" title="Off-label" class="mw-redirect">off-label</a> in several studies. In the largest study conducted so far, bevacizumab infusion was associated with a decrease in cardiac output and reduced duration and number of episodes of epistaxis in treated HHT patients.<sup id="cite_ref-pmid22396517_20-0" class="reference"><a href="#cite_note-pmid22396517-20"><span>[</span>20<span>]</span></a></sup> <a href="/wiki/Thalidomide" title="Thalidomide">Thalidomide</a>, another anti-<a href="/wiki/Angiogenesis" title="Angiogenesis">angiogenesis</a> drug, was also reported to have beneficial effects in HHT patients.<sup id="cite_ref-pmid23143669_21-0" class="reference"><a href="#cite_note-pmid23143669-21"><span>[</span>21<span>]</span></a></sup> Thalidomide treatment was found to induce vessel maturation in an experimental mouse model of HHT and to reduce the severity and frequency of nosebleeds in the majority of a small group of HHT patients. The blood hemoglobin levels of these treated patients rose as a result of reduced hemorrhage and enhanced blood vessel stabilization.<sup id="cite_ref-pmid20364125_22-0" class="reference"><a href="#cite_note-pmid20364125-22"><span>[</span>22<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Epidemiology">Epidemiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hereditary_hemorrhagic_telangiectasia&amp;action=edit&amp;section=19" title="Edit section: Epidemiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:LocationNetherlandsAntillesWithAruba.png" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/1/18/LocationNetherlandsAntillesWithAruba.png/220px-LocationNetherlandsAntillesWithAruba.png" width="220" height="101" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/1/18/LocationNetherlandsAntillesWithAruba.png 1.5x, //upload.wikimedia.org/wikipedia/commons/1/18/LocationNetherlandsAntillesWithAruba.png 2x" data-file-width="250" data-file-height="115" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:LocationNetherlandsAntillesWithAruba.png" class="internal" title="Enlarge"></a></div>
The <a href="/wiki/Netherlands_Antilles" title="Netherlands Antilles">Netherlands Antilles</a>, where HHT is more common than anywhere in the world, located off the coast of Venezuela.</div>
</div>
</div>
<p>Population studies from numerous areas in the world have shown that HHT occurs at roughly the same rate in almost all populations: somewhere around 1 in 5000. In some areas, it is much more common; for instance, in the <a href="/wiki/France" title="France">French</a> region of <a href="/wiki/Jura_Mountains" title="Jura Mountains">Haut Jura</a> the rate is 1:2351 - twice as common as in other populations. This has been attributed to a <a href="/wiki/Founder_effect" title="Founder effect">founder effect</a>, in which a population descending from a small number of ancestors has a high rate of a particular genetic trait because one of these ancestors harbored this trait.<sup id="cite_ref-Abdalla_8-6" class="reference"><a href="#cite_note-Abdalla-8"><span>[</span>8<span>]</span></a></sup> In Haut Jura, this has been shown to be the result of a particular <i>ACVRL1</i> mutation (named c.1112dupG or c.1112_1113insG).<sup id="cite_ref-Dupuis_2-25" class="reference"><a href="#cite_note-Dupuis-2"><span>[</span>2<span>]</span></a></sup> The highest rate of HHT is 1:1331, reported in <a href="/wiki/Bonaire" title="Bonaire">Bonaire</a> and <a href="/wiki/Cura%C3%A7ao" title="Curaçao">Curaçao</a>, two islands in the <a href="/wiki/Caribbean_Sea" title="Caribbean Sea">Caribbean</a> belonging to the <a href="/wiki/Netherlands_Antilles" title="Netherlands Antilles">Netherlands Antilles</a>.<sup id="cite_ref-Abdalla_8-7" class="reference"><a href="#cite_note-Abdalla-8"><span>[</span>8<span>]</span></a></sup></p>
<p>Most people with HHT have a normal lifespan.<sup id="cite_ref-Shovlin_1-25" class="reference"><a href="#cite_note-Shovlin-1"><span>[</span>1<span>]</span></a></sup> The skin lesions and nosebleeds tend to develop during childhood. AVMs are probably present from birth, but don't necessarily cause any symptoms. Frequent nosebleeds are the most common symptom and can significantly affect <a href="/wiki/Quality_of_life" title="Quality of life">quality of life</a>.<sup id="cite_ref-Guideline_7-27" class="reference"><a href="#cite_note-Guideline-7"><span>[</span>7<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="History">History</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hereditary_hemorrhagic_telangiectasia&amp;action=edit&amp;section=20" title="Edit section: History">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Several 19th century English physicians, starting with <a href="/wiki/Henry_Gawen_Sutton" title="Henry Gawen Sutton">Henry Gawen Sutton</a> (1836–1891)<sup id="cite_ref-23" class="reference"><a href="#cite_note-23"><span>[</span>23<span>]</span></a></sup> and followed by <a href="/wiki/Benjamin_Guy_Babington" title="Benjamin Guy Babington">Benjamin Guy Babington</a> (1794–1866)<sup id="cite_ref-24" class="reference"><a href="#cite_note-24"><span>[</span>24<span>]</span></a></sup> and <a href="/wiki/John_Wickham_Legg" title="John Wickham Legg">John Wickham Legg</a> (1843–1921),<sup id="cite_ref-25" class="reference"><a href="#cite_note-25"><span>[</span>25<span>]</span></a></sup> described the most common features of HHT, particularly the recurrent nosebleeds and the hereditary nature of the disease. The French physician Henri Jules Louis Marie Rendu (1844–1902) observed the skin and mucosal lesions, and distinguished the condition from <a href="/wiki/Hemophilia" title="Hemophilia" class="mw-redirect">hemophilia</a>.<sup id="cite_ref-26" class="reference"><a href="#cite_note-26"><span>[</span>26<span>]</span></a></sup> The Canadian-born Sir William Osler (1849–1919), then at <a href="/wiki/Johns_Hopkins_Hospital" title="Johns Hopkins Hospital">Johns Hopkins Hospital</a> and later at <a href="/wiki/Oxford_University" title="Oxford University" class="mw-redirect">Oxford University</a>, made further contributions with a 1901 report in which he described characteristic lesions in the <a href="/wiki/Digestive_tract" title="Digestive tract" class="mw-redirect">digestive tract</a>.<sup id="cite_ref-27" class="reference"><a href="#cite_note-27"><span>[</span>27<span>]</span></a></sup> The English physician Frederick Parkes Weber (1863–1962) reported further on the condition in 1907 with a series of cases.<sup id="cite_ref-28" class="reference"><a href="#cite_note-28"><span>[</span>28<span>]</span></a></sup> The term "hereditary hemorrhagic telangiectasia" was first used by the American physician Frederic M. Hanes (1883–1946) in a 1909 article on the condition.<sup id="cite_ref-Fuchizaki_3-1" class="reference"><a href="#cite_note-Fuchizaki-3"><span>[</span>3<span>]</span></a></sup><sup id="cite_ref-29" class="reference"><a href="#cite_note-29"><span>[</span>29<span>]</span></a></sup></p>
<p>The diagnosis of HHT remained a clinical one until the genetic defects that cause HHT were identified by a research group at <a href="/wiki/Duke_University_Hospital" title="Duke University Hospital">Duke University Medical Center</a>, in 1994 and 1996 respectively.<sup id="cite_ref-McAllister1994_9-1" class="reference"><a href="#cite_note-McAllister1994-9"><span>[</span>9<span>]</span></a></sup><sup id="cite_ref-Johnson1996_10-1" class="reference"><a href="#cite_note-Johnson1996-10"><span>[</span>10<span>]</span></a></sup> In 2000, the international scientific advisory committee of HHT Foundation International published the now widely used Curaçao criteria.<sup id="cite_ref-Guideline_7-28" class="reference"><a href="#cite_note-Guideline-7"><span>[</span>7<span>]</span></a></sup><sup id="cite_ref-Shovlin2000_15-1" class="reference"><a href="#cite_note-Shovlin2000-15"><span>[</span>15<span>]</span></a></sup> In 2006, a group of international experts met in <a href="/wiki/Canada" title="Canada">Canada</a> and formulated an <a href="/wiki/Evidence-based_medicine" title="Evidence-based medicine">evidence-based</a> <a href="/wiki/Medical_guideline" title="Medical guideline">guideline</a>, sponsored by the HHT Foundation International.<sup id="cite_ref-Guideline_7-29" class="reference"><a href="#cite_note-Guideline-7"><span>[</span>7<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hereditary_hemorrhagic_telangiectasia&amp;action=edit&amp;section=21" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-count references-column-count-2" style="-moz-column-count: 2; -webkit-column-count: 2; column-count: 2; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-Shovlin-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-Shovlin_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Shovlin_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Shovlin_1-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Shovlin_1-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Shovlin_1-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Shovlin_1-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Shovlin_1-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Shovlin_1-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Shovlin_1-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Shovlin_1-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Shovlin_1-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Shovlin_1-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-Shovlin_1-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-Shovlin_1-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-Shovlin_1-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-Shovlin_1-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-Shovlin_1-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-Shovlin_1-17"><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-Shovlin_1-18"><sup><i><b>s</b></i></sup></a> <a href="#cite_ref-Shovlin_1-19"><sup><i><b>t</b></i></sup></a> <a href="#cite_ref-Shovlin_1-20"><sup><i><b>u</b></i></sup></a> <a href="#cite_ref-Shovlin_1-21"><sup><i><b>v</b></i></sup></a> <a href="#cite_ref-Shovlin_1-22"><sup><i><b>w</b></i></sup></a> <a href="#cite_ref-Shovlin_1-23"><sup><i><b>x</b></i></sup></a> <a href="#cite_ref-Shovlin_1-24"><sup><i><b>y</b></i></sup></a> <a href="#cite_ref-Shovlin_1-25"><sup><i><b>z</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Govani FS, Shovlin CL (July 2009). <a rel="nofollow" class="external text" href="http://www.nature.com/ejhg/journal/v17/n7/full/ejhg200935a.html">"Hereditary haemorrhagic telangiectasia: a clinical and scientific review"</a>. <i>European Journal of Human Genetics</i> <b>17</b> (7): 860–71. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fejhg.2009.35">10.1038/ejhg.2009.35</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2986493">2986493</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19337313">19337313</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHereditary+hemorrhagic+telangiectasia&amp;rft.atitle=Hereditary+haemorrhagic+telangiectasia%3A+a+clinical+and+scientific+review&amp;rft.au=Govani+FS%2C+Shovlin+CL&amp;rft.aulast=Govani+FS%2C+Shovlin+CL&amp;rft.date=July+2009&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.nature.com%2Fejhg%2Fjournal%2Fv17%2Fn7%2Ffull%2Fejhg200935a.html&amp;rft_id=info%3Adoi%2F10.1038%2Fejhg.2009.35&amp;rft_id=info%3Apmc%2F2986493&amp;rft_id=info%3Apmid%2F19337313&amp;rft.issue=7&amp;rft.jtitle=European+Journal+of+Human+Genetics&amp;rft.pages=860-71&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=17" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Dupuis-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-Dupuis_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Dupuis_2-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Dupuis_2-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Dupuis_2-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Dupuis_2-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Dupuis_2-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Dupuis_2-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Dupuis_2-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Dupuis_2-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Dupuis_2-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Dupuis_2-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Dupuis_2-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-Dupuis_2-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-Dupuis_2-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-Dupuis_2-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-Dupuis_2-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-Dupuis_2-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-Dupuis_2-17"><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-Dupuis_2-18"><sup><i><b>s</b></i></sup></a> <a href="#cite_ref-Dupuis_2-19"><sup><i><b>t</b></i></sup></a> <a href="#cite_ref-Dupuis_2-20"><sup><i><b>u</b></i></sup></a> <a href="#cite_ref-Dupuis_2-21"><sup><i><b>v</b></i></sup></a> <a href="#cite_ref-Dupuis_2-22"><sup><i><b>w</b></i></sup></a> <a href="#cite_ref-Dupuis_2-23"><sup><i><b>x</b></i></sup></a> <a href="#cite_ref-Dupuis_2-24"><sup><i><b>y</b></i></sup></a> <a href="#cite_ref-Dupuis_2-25"><sup><i><b>z</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Dupuis-Girod S, Bailly S, Plauchu H (March 2010). "Hereditary hemorrhagic telangiectasia (HHT): from molecular biology to patient care". <i>J. Thromb. Haemost.</i> <b>8</b> (7): 1447–56. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1538-7836.2010.03860.x">10.1111/j.1538-7836.2010.03860.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20345718">20345718</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHereditary+hemorrhagic+telangiectasia&amp;rft.atitle=Hereditary+hemorrhagic+telangiectasia+%28HHT%29%3A+from+molecular+biology+to+patient+care&amp;rft.au=Dupuis-Girod+S%2C+Bailly+S%2C+Plauchu+H&amp;rft.aulast=Dupuis-Girod+S%2C+Bailly+S%2C+Plauchu+H&amp;rft.date=March+2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1538-7836.2010.03860.x&amp;rft_id=info%3Apmid%2F20345718&amp;rft.issue=7&amp;rft.jtitle=J.+Thromb.+Haemost.&amp;rft.pages=1447-56&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=8" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Fuchizaki-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-Fuchizaki_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Fuchizaki_3-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Fuchizaki U, Miyamori H, Kitagawa S, Kaneko S, Kobayashi K (November 2003). "Hereditary haemorrhagic telangiectasia (Rendu–Osler–Weber disease)". <i>Lancet</i> <b>362</b> (9394): 1490–4. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2803%2914696-X">10.1016/S0140-6736(03)14696-X</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14602446">14602446</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHereditary+hemorrhagic+telangiectasia&amp;rft.atitle=Hereditary+haemorrhagic+telangiectasia+%28Rendu%E2%80%93Osler%E2%80%93Weber+disease%29&amp;rft.au=Fuchizaki+U%2C+Miyamori+H%2C+Kitagawa+S%2C+Kaneko+S%2C+Kobayashi+K&amp;rft.aulast=Fuchizaki+U%2C+Miyamori+H%2C+Kitagawa+S%2C+Kaneko+S%2C+Kobayashi+K&amp;rft.date=November+2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2803%2914696-X&amp;rft_id=info%3Apmid%2F14602446&amp;rft.issue=9394&amp;rft.jtitle=Lancet&amp;rft.pages=1490-4&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=362" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Gossage-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-Gossage_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Gossage_4-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Gossage_4-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Gossage_4-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Gossage_4-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Gossage_4-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Gossage JR, Kanj G (August 1998). <a rel="nofollow" class="external text" href="http://ajrccm.atsjournals.org/cgi/content/full/158/2/643">"Pulmonary arteriovenous malformations. A state of the art review"</a>. <i>Am. J. Respir. Crit. Care Med.</i> <b>158</b> (2): 643–61. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1164%2Fajrccm.158.2.9711041">10.1164/ajrccm.158.2.9711041</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9700146">9700146</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHereditary+hemorrhagic+telangiectasia&amp;rft.atitle=Pulmonary+arteriovenous+malformations.+A+state+of+the+art+review&amp;rft.au=Gossage+JR%2C+Kanj+G&amp;rft.aulast=Gossage+JR%2C+Kanj+G&amp;rft.date=August+1998&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fajrccm.atsjournals.org%2Fcgi%2Fcontent%2Ffull%2F158%2F2%2F643&amp;rft_id=info%3Adoi%2F10.1164%2Fajrccm.158.2.9711041&amp;rft_id=info%3Apmid%2F9700146&amp;rft.issue=2&amp;rft.jtitle=Am.+J.+Respir.+Crit.+Care+Med.&amp;rft.pages=643-61&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=158" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Faughnan-5"><span class="mw-cite-backlink">^ <a href="#cite_ref-Faughnan_5-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Faughnan_5-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Faughnan_5-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Faughnan_5-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Faughnan_5-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Faughnan_5-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Faughnan_5-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Faughnan_5-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Faughnan_5-8"><sup><i><b>i</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Faughnan ME, Granton JT, Young LH (May 2009). "The pulmonary vascular complications of hereditary haemorrhagic telangiectasia". <i>Eur. Respir. J.</i> <b>33</b> (5): 1186–94. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1183%2F09031936.00061308">10.1183/09031936.00061308</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19407052">19407052</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHereditary+hemorrhagic+telangiectasia&amp;rft.atitle=The+pulmonary+vascular+complications+of+hereditary+haemorrhagic+telangiectasia&amp;rft.au=Faughnan+ME%2C+Granton+JT%2C+Young+LH&amp;rft.aulast=Faughnan+ME%2C+Granton+JT%2C+Young+LH&amp;rft.date=May+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1183%2F09031936.00061308&amp;rft_id=info%3Apmid%2F19407052&amp;rft.issue=5&amp;rft.jtitle=Eur.+Respir.+J.&amp;rft.pages=1186-94&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=33" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Buscarini-6"><span class="mw-cite-backlink">^ <a href="#cite_ref-Buscarini_6-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Buscarini_6-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Buscarini_6-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Buscarini_6-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Buscarini_6-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Buscarini_6-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Buscarini_6-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Buscarini_6-7"><sup><i><b>h</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Buscarini E, Plauchu H, Garcia Tsao G et al. (November 2006). "Liver involvement in hereditary hemorrhagic telangiectasia: consensus recommendations". <i>Liver Int.</i> <b>26</b> (9): 1040–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1478-3231.2006.01340.x">10.1111/j.1478-3231.2006.01340.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17032403">17032403</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHereditary+hemorrhagic+telangiectasia&amp;rft.atitle=Liver+involvement+in+hereditary+hemorrhagic+telangiectasia%3A+consensus+recommendations&amp;rft.au=Buscarini+E%2C+Plauchu+H%2C+Garcia+Tsao+G&amp;rft.aulast=Buscarini+E%2C+Plauchu+H%2C+Garcia+Tsao+G&amp;rft.date=November+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1478-3231.2006.01340.x&amp;rft_id=info%3Apmid%2F17032403&amp;rft.issue=9&amp;rft.jtitle=Liver+Int.&amp;rft.pages=1040-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=26" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-Guideline-7"><span class="mw-cite-backlink">^ <a href="#cite_ref-Guideline_7-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Guideline_7-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Guideline_7-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Guideline_7-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Guideline_7-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Guideline_7-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Guideline_7-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Guideline_7-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Guideline_7-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Guideline_7-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Guideline_7-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Guideline_7-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-Guideline_7-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-Guideline_7-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-Guideline_7-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-Guideline_7-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-Guideline_7-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-Guideline_7-17"><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-Guideline_7-18"><sup><i><b>s</b></i></sup></a> <a href="#cite_ref-Guideline_7-19"><sup><i><b>t</b></i></sup></a> <a href="#cite_ref-Guideline_7-20"><sup><i><b>u</b></i></sup></a> <a href="#cite_ref-Guideline_7-21"><sup><i><b>v</b></i></sup></a> <a href="#cite_ref-Guideline_7-22"><sup><i><b>w</b></i></sup></a> <a href="#cite_ref-Guideline_7-23"><sup><i><b>x</b></i></sup></a> <a href="#cite_ref-Guideline_7-24"><sup><i><b>y</b></i></sup></a> <a href="#cite_ref-Guideline_7-25"><sup><i><b>z</b></i></sup></a> <a href="#cite_ref-Guideline_7-26"><sup><i><b>aa</b></i></sup></a> <a href="#cite_ref-Guideline_7-27"><sup><i><b>ab</b></i></sup></a> <a href="#cite_ref-Guideline_7-28"><sup><i><b>ac</b></i></sup></a> <a href="#cite_ref-Guideline_7-29"><sup><i><b>ad</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Faughnan ME, Palda VA, Garcia-Tsao G et al. (2011). "International guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia". <i>Journal of Medical Genetics</i> <b>48</b> (2): 73–87. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1136%2Fjmg.2009.069013">10.1136/jmg.2009.069013</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19553198">19553198</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHereditary+hemorrhagic+telangiectasia&amp;rft.atitle=International+guidelines+for+the+diagnosis+and+management+of+hereditary+hemorrhagic+telangiectasia&amp;rft.au=Faughnan+ME%2C+Palda+VA%2C+Garcia-Tsao+G&amp;rft.aulast=Faughnan+ME%2C+Palda+VA%2C+Garcia-Tsao+G&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1136%2Fjmg.2009.069013&amp;rft_id=info%3Apmid%2F19553198&amp;rft.issue=2&amp;rft.jtitle=Journal+of+Medical+Genetics&amp;rft.pages=73-87&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=48" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-Abdalla-8"><span class="mw-cite-backlink">^ <a href="#cite_ref-Abdalla_8-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Abdalla_8-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Abdalla_8-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Abdalla_8-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Abdalla_8-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Abdalla_8-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Abdalla_8-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Abdalla_8-7"><sup><i><b>h</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Abdalla SA, Letarte M (February 2006). <a rel="nofollow" class="external text" href="http://jmg.bmj.com/content/43/2/97.long">"Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease"</a>. <i>Journal of Medical Genetics</i> <b>43</b> (2): 97–110. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1136%2Fjmg.2005.030833">10.1136/jmg.2005.030833</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2603035">2603035</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15879500">15879500</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHereditary+hemorrhagic+telangiectasia&amp;rft.atitle=Hereditary+haemorrhagic+telangiectasia%3A+current+views+on+genetics+and+mechanisms+of+disease&amp;rft.au=Abdalla+SA%2C+Letarte+M&amp;rft.aulast=Abdalla+SA%2C+Letarte+M&amp;rft.date=February+2006&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fjmg.bmj.com%2Fcontent%2F43%2F2%2F97.long&amp;rft_id=info%3Adoi%2F10.1136%2Fjmg.2005.030833&amp;rft_id=info%3Apmc%2F2603035&amp;rft_id=info%3Apmid%2F15879500&amp;rft.issue=2&amp;rft.jtitle=Journal+of+Medical+Genetics&amp;rft.pages=97-110&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=43" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-McAllister1994-9"><span class="mw-cite-backlink">^ <a href="#cite_ref-McAllister1994_9-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-McAllister1994_9-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">McAllister KA, Grogg KM, Johnson DW et al. (December 1994). "Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1". <i>Nat. Genet.</i> <b>8</b> (4): 345–51. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fng1294-345">10.1038/ng1294-345</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7894484">7894484</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHereditary+hemorrhagic+telangiectasia&amp;rft.atitle=Endoglin%2C+a+TGF-beta+binding+protein+of+endothelial+cells%2C+is+the+gene+for+hereditary+haemorrhagic+telangiectasia+type+1&amp;rft.aulast=McAllister+KA%2C+Grogg+KM%2C+Johnson+DW&amp;rft.au=McAllister+KA%2C+Grogg+KM%2C+Johnson+DW&amp;rft.date=December+1994&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fng1294-345&amp;rft_id=info%3Apmid%2F7894484&amp;rft.issue=4&amp;rft.jtitle=Nat.+Genet.&amp;rft.pages=345-51&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=8" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-Johnson1996-10"><span class="mw-cite-backlink">^ <a href="#cite_ref-Johnson1996_10-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Johnson1996_10-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Johnson DW, Berg JN, Baldwin MA et al. (June 1996). "Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2". <i>Nat. Genet.</i> <b>13</b> (2): 189–95. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fng0696-189">10.1038/ng0696-189</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8640225">8640225</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHereditary+hemorrhagic+telangiectasia&amp;rft.atitle=Mutations+in+the+activin+receptor-like+kinase+1+gene+in+hereditary+haemorrhagic+telangiectasia+type+2&amp;rft.au=Johnson+DW%2C+Berg+JN%2C+Baldwin+MA&amp;rft.aulast=Johnson+DW%2C+Berg+JN%2C+Baldwin+MA&amp;rft.date=June+1996&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fng0696-189&amp;rft_id=info%3Apmid%2F8640225&amp;rft.issue=2&amp;rft.jtitle=Nat.+Genet.&amp;rft.pages=189-95&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=13" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-11">^</a></b></span> <span class="reference-text"><span class="citation journal">Cole SG, Begbie ME, Wallace GM, Shovlin CL (2005). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1736109">"A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5"</a>. <i>Journal of Medical Genetics</i> <b>42</b> (7): 577–82. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1136%2Fjmg.2004.028712">10.1136/jmg.2004.028712</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1736109">1736109</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15994879">15994879</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHereditary+hemorrhagic+telangiectasia&amp;rft.atitle=A+new+locus+for+hereditary+haemorrhagic+telangiectasia+%28HHT3%29+maps+to+chromosome+5&amp;rft.au=Cole+SG%2C+Begbie+ME%2C+Wallace+GM%2C+Shovlin+CL&amp;rft.aulast=Cole+SG%2C+Begbie+ME%2C+Wallace+GM%2C+Shovlin+CL&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1736109&amp;rft_id=info%3Adoi%2F10.1136%2Fjmg.2004.028712&amp;rft_id=info%3Apmc%2F1736109&amp;rft_id=info%3Apmid%2F15994879&amp;rft.issue=7&amp;rft.jtitle=Journal+of+Medical+Genetics&amp;rft.pages=577-82&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=42" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><span class="citation journal">Bayrak-Toydemir P, McDonald J, Akarsu N et al. (2006). "A fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7". <i>American Journal of Medical Genetics</i> <b>140</b> (20): 2155–62. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fajmg.a.31450">10.1002/ajmg.a.31450</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16969873">16969873</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHereditary+hemorrhagic+telangiectasia&amp;rft.atitle=A+fourth+locus+for+hereditary+hemorrhagic+telangiectasia+maps+to+chromosome+7&amp;rft.au=Bayrak-Toydemir+P%2C+McDonald+J%2C+Akarsu+N&amp;rft.aulast=Bayrak-Toydemir+P%2C+McDonald+J%2C+Akarsu+N&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fajmg.a.31450&amp;rft_id=info%3Apmid%2F16969873&amp;rft.issue=20&amp;rft.jtitle=American+Journal+of+Medical+Genetics&amp;rft.pages=2155-62&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=140" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-13">^</a></b></span> <span class="reference-text"><span class="citation journal">Gallione CJ, Repetto GM, Legius E et al. (March 2004). "A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4)". <i>Lancet</i> <b>363</b> (9412): 852–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2804%2915732-2">10.1016/S0140-6736(04)15732-2</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15031030">15031030</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHereditary+hemorrhagic+telangiectasia&amp;rft.atitle=A+combined+syndrome+of+juvenile+polyposis+and+hereditary+haemorrhagic+telangiectasia+associated+with+mutations+in+MADH4+%28SMAD4%29&amp;rft.au=Gallione+CJ%2C+Repetto+GM%2C+Legius+E&amp;rft.aulast=Gallione+CJ%2C+Repetto+GM%2C+Legius+E&amp;rft.date=March+2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2804%2915732-2&amp;rft_id=info%3Apmid%2F15031030&amp;rft.issue=9412&amp;rft.jtitle=Lancet&amp;rft.pages=852-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=363" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-Friedlander-14"><span class="mw-cite-backlink">^ <a href="#cite_ref-Friedlander_14-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Friedlander_14-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Friedlander_14-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Friedlander_14-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Friedlander_14-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Friedlander RM (June 2007). "Clinical practice. Arteriovenous malformations of the brain". <i>N. Engl. J. Med.</i> <b>356</b> (26): 2704–12. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJMcp067192">10.1056/NEJMcp067192</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17596605">17596605</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHereditary+hemorrhagic+telangiectasia&amp;rft.atitle=Clinical+practice.+Arteriovenous+malformations+of+the+brain&amp;rft.au=Friedlander+RM&amp;rft.aulast=Friedlander+RM&amp;rft.date=June+2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMcp067192&amp;rft_id=info%3Apmid%2F17596605&amp;rft.issue=26&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=2704-12&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=356" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Shovlin2000-15"><span class="mw-cite-backlink">^ <a href="#cite_ref-Shovlin2000_15-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Shovlin2000_15-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Shovlin CL, Guttmacher AE, Buscarini E et al. (Mar 2000). "Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu–Osler–Weber syndrome)". <i>American Journal of Medical Genetics</i> <b>91</b> (1): 66–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2F%28SICI%291096-8628%2820000306%2991%3A1%3C66%3A%3AAID-AJMG12%3E3.0.CO%3B2-P">10.1002/(SICI)1096-8628(20000306)91:1&lt;66::AID-AJMG12&gt;3.0.CO;2-P</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10751092">10751092</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHereditary+hemorrhagic+telangiectasia&amp;rft.atitle=Diagnostic+criteria+for+hereditary+hemorrhagic+telangiectasia+%28Rendu%E2%80%93Osler%E2%80%93Weber+syndrome%29&amp;rft.aulast=Shovlin+CL%2C+Guttmacher+AE%2C+Buscarini+E&amp;rft.au=Shovlin+CL%2C+Guttmacher+AE%2C+Buscarini+E&amp;rft.date=Mar+2000&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F%28SICI%291096-8628%2820000306%2991%3A1%3C66%3A%3AAID-AJMG12%3E3.0.CO%3B2-P&amp;rft_id=info%3Apmid%2F10751092&amp;rft.issue=1&amp;rft.jtitle=American+Journal+of+Medical+Genetics&amp;rft.pages=66-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=91" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-Geisthoff-16"><span class="mw-cite-backlink">^ <a href="#cite_ref-Geisthoff_16-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Geisthoff_16-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Geisthoff_16-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Geisthoff UW, Fiorella ML, Fiorella R (2006). "Treatment of recurrent epistaxis in HHT". <i>Curr. Pharm. Des.</i> <b>12</b> (10): 1237–42. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.2174%2F138161206776361255">10.2174/138161206776361255</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16611115">16611115</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHereditary+hemorrhagic+telangiectasia&amp;rft.atitle=Treatment+of+recurrent+epistaxis+in+HHT&amp;rft.au=Geisthoff+UW%2C+Fiorella+ML%2C+Fiorella+R&amp;rft.aulast=Geisthoff+UW%2C+Fiorella+ML%2C+Fiorella+R&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2174%2F138161206776361255&amp;rft_id=info%3Apmid%2F16611115&amp;rft.issue=10&amp;rft.jtitle=Curr.+Pharm.+Des.&amp;rft.pages=1237-42&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=12" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-17">^</a></b></span> <span class="reference-text"><span class="citation journal">Saunders WH (1963). "Septal dermoplasty: a new operative procedure for control of nosebleeds in patients with hereditary hæmorrhagic telangiectasia". <i>J. Laryngol. Otol.</i> <b>77</b> (01): 69–76. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1017%2FS0022215100060382">10.1017/S0022215100060382</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/13986828">13986828</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHereditary+hemorrhagic+telangiectasia&amp;rft.atitle=Septal+dermoplasty%3A+a+new+operative+procedure+for+control+of+nosebleeds+in+patients+with+hereditary+h%C3%A6morrhagic+telangiectasia&amp;rft.aulast=Saunders+WH&amp;rft.au=Saunders+WH&amp;rft.date=1963&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1017%2FS0022215100060382&amp;rft_id=info%3Apmid%2F13986828&amp;rft.issue=01&amp;rft.jtitle=J.+Laryngol.+Otol.&amp;rft.pages=69-76&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=77" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-18">^</a></b></span> <span class="reference-text"><span class="citation journal">Young A (May 1967). "Closure of the nostrils in atrophic rhinitis". <i>J. Laryngol. Otol.</i> <b>81</b> (5): 515–24. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1017%2FS0022215100067426">10.1017/S0022215100067426</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/6024992">6024992</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHereditary+hemorrhagic+telangiectasia&amp;rft.atitle=Closure+of+the+nostrils+in+atrophic+rhinitis&amp;rft.aulast=Young+A&amp;rft.au=Young+A&amp;rft.date=May+1967&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1017%2FS0022215100067426&amp;rft_id=info%3Apmid%2F6024992&amp;rft.issue=5&amp;rft.jtitle=J.+Laryngol.+Otol.&amp;rft.pages=515-24&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=81" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20870325-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20870325_19-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Shovlin CL (2010). "Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment". <i>Blood Rev</i> <b>24</b> (6): 203–19. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.blre.2010.07.001">10.1016/j.blre.2010.07.001</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20870325">20870325</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHereditary+hemorrhagic+telangiectasia&amp;rft.atitle=Hereditary+haemorrhagic+telangiectasia%3A+pathophysiology%2C+diagnosis+and+treatment&amp;rft.aulast=Shovlin+CL&amp;rft.au=Shovlin+CL&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.blre.2010.07.001&amp;rft_id=info%3Apmid%2F20870325&amp;rft.issue=6&amp;rft.jtitle=Blood+Rev&amp;rft.pages=203-19&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=24" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid22396517-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid22396517_20-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Dupuis-Girod S, Ginon I, Saurin JC, Marion D, Guillot E, Decullier E, Roux A, Carette MF, Gilbert-Dussardier B, Hatron PY, Lacombe P, Lorcerie B, Rivière S, Corre R, Giraud S, Bailly S, Paintaud G, Ternant D, Valette PJ, Plauchu H, Faure F (2012). "Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output". <i>JAMA</i> <b>307</b> (9): 948–55. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1001%2Fjama.2012.250">10.1001/jama.2012.250</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22396517">22396517</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHereditary+hemorrhagic+telangiectasia&amp;rft.atitle=Bevacizumab+in+patients+with+hereditary+hemorrhagic+telangiectasia+and+severe+hepatic+vascular+malformations+and+high+cardiac+output&amp;rft.au=Dupuis-Girod+S%2C+Ginon+I%2C+Saurin+JC%2C+Marion+D%2C+Guillot+E%2C+Decullier+E%2C+Roux+A%2C+Carette+MF%2C+Gilbert-Dussardier+B%2C+Hatron+PY%2C+Lacombe+P%2C+Lorcerie+B%2C+Rivi%C3%A8re+S%2C+Corre+R%2C+Giraud+S%2C+Bailly+S%2C+Paintaud+G%2C+Ternant+D%2C+Valette+PJ%2C+Plauchu+H%2C+Faure+F&amp;rft.aulast=Dupuis-Girod+S%2C+Ginon+I%2C+Saurin+JC%2C+Marion+D%2C+Guillot+E%2C+Decullier+E%2C+Roux+A%2C+Carette+MF%2C+Gilbert-Dussardier+B%2C+Hatron+PY%2C+Lacombe+P%2C+Lorcerie+B%2C+Rivi%C3%A8re+S%2C+Corre+R%2C+Giraud+S%2C+Bailly+S%2C+Paintaud+G%2C+Ternant+D%2C+Valette+PJ%2C+Plauchu+H%2C+Faure+F&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.2012.250&amp;rft_id=info%3Apmid%2F22396517&amp;rft.issue=9&amp;rft.jtitle=JAMA&amp;rft.pages=948-55&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=307" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid23143669-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid23143669_21-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Franchini M, Frattini F, Crestani S, Bonfanti C (2012). "Novel treatments for epistaxis in hereditary hemorrhagic telangiectasia: a systematic review of the clinical experience with thalidomide". <i>J Thromb Thrombolysis</i> <b>36</b> (3): 355–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs11239-012-0840-5">10.1007/s11239-012-0840-5</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23143669">23143669</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHereditary+hemorrhagic+telangiectasia&amp;rft.atitle=Novel+treatments+for+epistaxis+in+hereditary+hemorrhagic+telangiectasia%3A+a+systematic+review+of+the+clinical+experience+with+thalidomide&amp;rft.au=Franchini+M%2C+Frattini+F%2C+Crestani+S%2C+Bonfanti+C&amp;rft.aulast=Franchini+M%2C+Frattini+F%2C+Crestani+S%2C+Bonfanti+C&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs11239-012-0840-5&amp;rft_id=info%3Apmid%2F23143669&amp;rft.issue=3&amp;rft.jtitle=J+Thromb+Thrombolysis&amp;rft.pages=355-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=36" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20364125-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20364125_22-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Lebrin F, Srun S, Raymond K, Martin S, van den Brink S, Freitas C, Bréant C, Mathivet T, Larrivée B, Thomas JL, Arthur HM, Westermann CJ, Disch F, Mager JJ, Snijder RJ, Eichmann A, Mummery CL (2010). "Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia". <i>Nat Med</i> <b>16</b> (4): 420–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fnm.2131">10.1038/nm.2131</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20364125">20364125</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHereditary+hemorrhagic+telangiectasia&amp;rft.atitle=Thalidomide+stimulates+vessel+maturation+and+reduces+epistaxis+in+individuals+with+hereditary+hemorrhagic+telangiectasia&amp;rft.aulast=Lebrin+F%2C+Srun+S%2C+Raymond+K%2C+Martin+S%2C+van+den+Brink+S%2C+Freitas+C%2C+Br%C3%A9ant+C%2C+Mathivet+T%2C+Larriv%C3%A9e+B%2C+Thomas+JL%2C+Arthur+HM%2C+Westermann+CJ%2C+Disch+F%2C+Mager+JJ%2C+Snijder+RJ%2C+Eichmann+A%2C+Mummery+CL&amp;rft.au=Lebrin+F%2C+Srun+S%2C+Raymond+K%2C+Martin+S%2C+van+den+Brink+S%2C+Freitas+C%2C+Br%C3%A9ant+C%2C+Mathivet+T%2C+Larriv%C3%A9e+B%2C+Thomas+JL%2C+Arthur+HM%2C+Westermann+CJ%2C+Disch+F%2C+Mager+JJ%2C+Snijder+RJ%2C+Eichmann+A%2C+Mummery+CL&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fnm.2131&amp;rft_id=info%3Apmid%2F20364125&amp;rft.issue=4&amp;rft.jtitle=Nat+Med&amp;rft.pages=420-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=16" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-23">^</a></b></span> <span class="reference-text"><span class="citation journal">Sutton HG (1864). "Epistaxis as an indication of impaired nutrition, and of degeneration of the vascular system". <i>Med. Mirror</i>: 769–81.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHereditary+hemorrhagic+telangiectasia&amp;rft.atitle=Epistaxis+as+an+indication+of+impaired+nutrition%2C+and+of+degeneration+of+the+vascular+system&amp;rft.aulast=Sutton+HG&amp;rft.au=Sutton+HG&amp;rft.date=1864&amp;rft.genre=article&amp;rft.jtitle=Med.+Mirror&amp;rft.pages=769-81&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-24">^</a></b></span> <span class="reference-text"><span class="citation journal">Babington BG (1865). "Hereditary epistaxis". <i>Lancet</i> <b>2</b> (2195): 362–363. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2802%2955197-7">10.1016/S0140-6736(02)55197-7</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHereditary+hemorrhagic+telangiectasia&amp;rft.atitle=Hereditary+epistaxis&amp;rft.au=Babington+BG&amp;rft.aulast=Babington+BG&amp;rft.date=1865&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2802%2955197-7&amp;rft.issue=2195&amp;rft.jtitle=Lancet&amp;rft.pages=362-363&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><span class="citation journal">Legg W (1876). "A case of haemophilia complicated with multiple naevi". <i>Lancet</i> <b>2</b> (2781): 856–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2802%2949594-3">10.1016/S0140-6736(02)49594-3</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHereditary+hemorrhagic+telangiectasia&amp;rft.atitle=A+case+of+haemophilia+complicated+with+multiple+naevi&amp;rft.aulast=Legg+W&amp;rft.au=Legg+W&amp;rft.date=1876&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2802%2949594-3&amp;rft.issue=2781&amp;rft.jtitle=Lancet&amp;rft.pages=856-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-26">^</a></b></span> <span class="reference-text"><span class="citation journal">Rendu HJ (1896). "Épistaxis répétées chez un sujet porteur de petits angiomes cutanés et muqueux". <i>Gaz. Hop.</i>: 1322–3.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHereditary+hemorrhagic+telangiectasia&amp;rft.atitle=%C3%89pistaxis+r%C3%A9p%C3%A9t%C3%A9es+chez+un+sujet+porteur+de+petits+angiomes+cutan%C3%A9s+et+muqueux&amp;rft.aulast=Rendu+HJ&amp;rft.au=Rendu+HJ&amp;rft.date=1896&amp;rft.genre=article&amp;rft.jtitle=Gaz.+Hop.&amp;rft.pages=1322-3&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-27">^</a></b></span> <span class="reference-text"><span class="citation journal">Osler W (1901). "On a family form of recurring epistaxis, associated with multiple telangiectases of the skin and mucous membranes". <i>Bull. Johns Hopkins Hosp.</i> <b>12</b>: 333–7.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHereditary+hemorrhagic+telangiectasia&amp;rft.atitle=On+a+family+form+of+recurring+epistaxis%2C+associated+with+multiple+telangiectases+of+the+skin+and+mucous+membranes&amp;rft.aulast=Osler+W&amp;rft.au=Osler+W&amp;rft.date=1901&amp;rft.genre=article&amp;rft.jtitle=Bull.+Johns+Hopkins+Hosp.&amp;rft.pages=333-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=12" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-28">^</a></b></span> <span class="reference-text"><span class="citation journal">Weber FP (1907). "Multiple hereditary developmental angiomata (telangiectases) of the skin and mucous membranes associated with recurring haemorrhages". <i>Lancet</i> <b>2</b> (4377): 160–162. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2800%2932590-9">10.1016/S0140-6736(00)32590-9</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHereditary+hemorrhagic+telangiectasia&amp;rft.atitle=Multiple+hereditary+developmental+angiomata+%28telangiectases%29+of+the+skin+and+mucous+membranes+associated+with+recurring+haemorrhages&amp;rft.aulast=Weber+FP&amp;rft.au=Weber+FP&amp;rft.date=1907&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2800%2932590-9&amp;rft.issue=4377&amp;rft.jtitle=Lancet&amp;rft.pages=160-162&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-29">^</a></b></span> <span class="reference-text"><span class="citation journal">Hanes FM (1909). "Multiple hereditary telangiectasis causing hemorrhage (hereditary hemorrhagic telangiectasia)". <i>Bull. Johns Hopkins Hosp.</i> <b>20</b>: 63–73.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHereditary+hemorrhagic+telangiectasia&amp;rft.atitle=Multiple+hereditary+telangiectasis+causing+hemorrhage+%28hereditary+hemorrhagic+telangiectasia%29&amp;rft.au=Hanes+FM&amp;rft.aulast=Hanes+FM&amp;rft.date=1909&amp;rft.genre=article&amp;rft.jtitle=Bull.+Johns+Hopkins+Hosp.&amp;rft.pages=63-73&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=20" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hereditary_hemorrhagic_telangiectasia&amp;action=edit&amp;section=22" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><a rel="nofollow" class="external text" href="http://www.hht.org">HHT Foundation International</a></li>
<li><a rel="nofollow" class="external text" href="http://www.hhtmutation.org">HHT mutation database</a> (<i>ENG</i> and <i>ACVRL1</i>)</li>
</ul>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks hlist collapsible collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Vascular_diseases" title="Template:Vascular diseases"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Vascular_diseases" title="Template talk:Vascular diseases"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Vascular_diseases&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">
<ul>
<li><a href="/wiki/Cardiovascular_disease" title="Cardiovascular disease">Cardiovascular disease</a>: <a href="/wiki/Vascular_disease" title="Vascular disease">vascular disease</a></li>
<li><a href="/wiki/Circulatory_system" title="Circulatory system">Circulatory system</a> <a href="/wiki/Pathology" title="Pathology">pathology</a>
<ul>
<li><a href="/wiki/ICD-10_Chapter_IX:_Diseases_of_the_circulatory_system#.28I70.E2.80.93I79.29_Diseases_of_arteries.2C_arterioles_and_capillaries" title="ICD-10 Chapter IX: Diseases of the circulatory system">I70–I99</a>, <a href="/wiki/List_of_ICD-9_codes_390%E2%80%93459:_diseases_of_the_circulatory_system#Diseases_of_arteries.2C_arterioles.2C_and_capillaries_.28440.E2.80.93448.29" title="List of ICD-9 codes 390–459: diseases of the circulatory system">440–456</a></li>
</ul>
</li>
</ul>
</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Artery" title="Artery">Arteries</a>, <a href="/wiki/Arteriole" title="Arteriole">arterioles</a><br />
and <a href="/wiki/Capillary" title="Capillary">capillaries</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Inflammation" title="Inflammation">Inflammation</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Arteritis" title="Arteritis">Arteritis</a>
<ul>
<li><a href="/wiki/Aortitis" title="Aortitis">Aortitis</a></li>
</ul>
</li>
<li><a href="/wiki/Thromboangiitis_obliterans" title="Thromboangiitis obliterans">Buerger's disease</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Peripheral_vascular_disease" title="Peripheral vascular disease" class="mw-redirect">Arterial occlusive disease</a> /<br />
<a href="/wiki/Peripheral_vascular_disease" title="Peripheral vascular disease" class="mw-redirect">peripheral vascular disease</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Arteriosclerosis" title="Arteriosclerosis">Arteriosclerosis</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Atherosclerosis" title="Atherosclerosis">Atherosclerosis</a>
<ul>
<li><a href="/wiki/Foam_cell" title="Foam cell">Foam cell</a></li>
<li><a href="/wiki/Fatty_streak" title="Fatty streak">Fatty streak</a></li>
<li><a href="/wiki/Atheroma" title="Atheroma">Atheroma</a></li>
<li><a href="/wiki/Intermittent_claudication" title="Intermittent claudication">Intermittent claudication</a></li>
<li><a href="/wiki/Critical_limb_ischemia" title="Critical limb ischemia">Critical limb ischemia</a></li>
</ul>
</li>
</ul>
<ul>
<li><a href="/wiki/Monckeberg%27s_arteriosclerosis" title="Monckeberg's arteriosclerosis">Monckeberg's arteriosclerosis</a></li>
<li><a href="/wiki/Arteriolosclerosis" title="Arteriolosclerosis">Arteriolosclerosis</a>
<ul>
<li><a href="/wiki/Hyaline_arteriolosclerosis" title="Hyaline arteriolosclerosis">Hyaline</a></li>
<li><a href="/wiki/Hyperplastic_arteriolosclerosis" title="Hyperplastic arteriolosclerosis">Hyperplastic</a></li>
<li><a href="/wiki/Cholesterol" title="Cholesterol">Cholesterol</a></li>
<li><a href="/wiki/Low-density_lipoprotein" title="Low-density lipoprotein">LDL</a></li>
<li><a href="/wiki/Oxycholesterol" title="Oxycholesterol">Oxycholesterol</a></li>
<li><a href="/wiki/Trans_fat" title="Trans fat">Trans fat</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Stenosis" title="Stenosis">Stenosis</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Carotid_artery_stenosis" title="Carotid artery stenosis">Carotid artery stenosis</a></li>
<li><a href="/wiki/Renal_artery_stenosis" title="Renal artery stenosis">Renal artery stenosis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Aortoiliac_occlusive_disease" title="Aortoiliac occlusive disease">Aortoiliac occlusive disease</a></li>
<li><a href="/wiki/Degos_disease" title="Degos disease">Degos disease</a></li>
<li><a href="/wiki/Erythromelalgia" title="Erythromelalgia">Erythromelalgia</a></li>
<li><a href="/wiki/Fibromuscular_dysplasia" title="Fibromuscular dysplasia">Fibromuscular dysplasia</a></li>
<li><a href="/wiki/Raynaud%27s_phenomenon" title="Raynaud's phenomenon">Raynaud's phenomenon</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Aneurysm" title="Aneurysm">Aneurysm</a> / <a href="/wiki/Dissection_(medical)" title="Dissection (medical)">dissection</a> /<br />
<a href="/wiki/Pseudoaneurysm" title="Pseudoaneurysm">pseudoaneurysm</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i>torso</i>: <a href="/wiki/Aortic_aneurysm" title="Aortic aneurysm">Aortic aneurysm</a>
<ul>
<li><a href="/wiki/Abdominal_aortic_aneurysm" title="Abdominal aortic aneurysm">Abdominal aortic aneurysm</a></li>
<li><a href="/wiki/Thoracic_aortic_aneurysm" title="Thoracic aortic aneurysm">Thoracic aortic aneurysm</a></li>
</ul>
</li>
<li><a href="/wiki/Aortic_dissection" title="Aortic dissection">Aortic dissection</a></li>
<li><a href="/wiki/Coronary_artery_aneurysm" title="Coronary artery aneurysm">Coronary artery aneurysm</a></li>
<li><i>head / neck</i>
<ul>
<li><a href="/wiki/Intracranial_aneurysm" title="Intracranial aneurysm">Intracranial aneurysm</a></li>
<li><a href="/wiki/Intracranial_berry_aneurysm" title="Intracranial berry aneurysm" class="mw-redirect">Intracranial berry aneurysm</a></li>
<li><a href="/wiki/Carotid_artery_dissection" title="Carotid artery dissection">Carotid artery dissection</a></li>
<li><a href="/wiki/Vertebral_artery_dissection" title="Vertebral artery dissection">Vertebral artery dissection</a></li>
<li><a href="/wiki/Familial_aortic_dissection" title="Familial aortic dissection">Familial aortic dissection</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Vascular_malformation" title="Vascular malformation">Vascular malformation</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Arteriovenous_fistula" title="Arteriovenous fistula">Arteriovenous fistula</a></li>
<li><a href="/wiki/Arteriovenous_malformation" title="Arteriovenous malformation">Arteriovenous malformation</a></li>
<li><a href="/wiki/Telangiectasia" title="Telangiectasia">Telangiectasia</a>
<ul>
<li><strong class="selflink">Hereditary hemorrhagic telangiectasia</strong></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Nevus#Vascular_nevus" title="Nevus">Vascular nevus</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Cherry_hemangioma" title="Cherry hemangioma">Cherry hemangioma</a></li>
<li><a href="/wiki/Halo_nevus" title="Halo nevus">Halo nevus</a></li>
<li><a href="/wiki/Spider_angioma" title="Spider angioma">Spider angioma</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Vein" title="Vein">Veins</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Inflammation" title="Inflammation">Inflammation</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Phlebitis" title="Phlebitis">Phlebitis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Venous_thrombosis" title="Venous thrombosis">Venous thrombosis</a> /<br />
<a href="/wiki/Thrombophlebitis" title="Thrombophlebitis">Thrombophlebitis</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i>primarily lower limb</i>
<ul>
<li><a href="/wiki/Deep_vein_thrombosis" title="Deep vein thrombosis">Deep vein thrombosis</a></li>
</ul>
</li>
<li><i>abdomen</i>
<ul>
<li><a href="/wiki/Hepatic_veno-occlusive_disease" title="Hepatic veno-occlusive disease">Hepatic veno-occlusive disease</a></li>
<li><a href="/wiki/Budd%E2%80%93Chiari_syndrome" title="Budd–Chiari syndrome">Budd–Chiari syndrome</a></li>
<li><a href="/wiki/May%E2%80%93Thurner_syndrome" title="May–Thurner syndrome">May–Thurner syndrome</a></li>
<li><a href="/wiki/Portal_vein_thrombosis" title="Portal vein thrombosis">Portal vein thrombosis</a></li>
<li><a href="/wiki/Renal_vein_thrombosis" title="Renal vein thrombosis">Renal vein thrombosis</a></li>
</ul>
</li>
<li><i>upper limb / torso</i>
<ul>
<li><a href="/wiki/Mondor%27s_disease" title="Mondor's disease">Mondor's disease</a></li>
<li><a href="/wiki/Paget%E2%80%93Schroetter_disease" title="Paget–Schroetter disease">Paget–Schroetter disease</a></li>
</ul>
</li>
<li><i>head</i>
<ul>
<li><a href="/wiki/Cerebral_venous_sinus_thrombosis" title="Cerebral venous sinus thrombosis">Cerebral venous sinus thrombosis</a></li>
</ul>
</li>
<li><a href="/wiki/Post-thrombotic_syndrome" title="Post-thrombotic syndrome">Post-thrombotic syndrome</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Varicose_veins" title="Varicose veins">Varicose veins</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Gastric_varices" title="Gastric varices">Gastric varices</a></li>
<li><a href="/wiki/Portacaval_anastomosis" title="Portacaval anastomosis">Portacaval anastomosis</a>
<ul>
<li><a href="/wiki/Caput_medusae" title="Caput medusae">Caput medusae</a></li>
<li><a href="/wiki/Esophageal_varices" title="Esophageal varices">Esophageal varices</a></li>
<li><a href="/wiki/Hemorrhoid" title="Hemorrhoid">Hemorrhoid</a></li>
</ul>
</li>
<li><a href="/wiki/Varicocele" title="Varicocele">Varicocele</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Chronic_venous_insufficiency" title="Chronic venous insufficiency">Chronic venous insufficiency</a></li>
<li><a href="/wiki/Chronic_cerebrospinal_venous_insufficiency" title="Chronic cerebrospinal venous insufficiency">Chronic cerebrospinal venous insufficiency</a></li>
<li><a href="/wiki/Superior_vena_cava_syndrome" title="Superior vena cava syndrome">Superior vena cava syndrome</a></li>
<li><a href="/wiki/Inferior_vena_cava_syndrome" title="Inferior vena cava syndrome">Inferior vena cava syndrome</a></li>
<li><a href="/wiki/Venous_ulcer" title="Venous ulcer">Venous ulcer</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Arteries or veins</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Angiopathy" title="Angiopathy">Angiopathy</a>
<ul>
<li><a href="/wiki/Macroangiopathy" title="Macroangiopathy" class="mw-redirect">Macroangiopathy</a></li>
<li><a href="/wiki/Microangiopathy" title="Microangiopathy">Microangiopathy</a></li>
</ul>
</li>
<li><a href="/wiki/Embolism" title="Embolism">Embolism</a>
<ul>
<li><a href="/wiki/Pulmonary_embolism" title="Pulmonary embolism">Pulmonary embolism</a></li>
<li><a href="/wiki/Cholesterol_embolism" title="Cholesterol embolism">Cholesterol embolism</a></li>
<li><a href="/wiki/Paradoxical_embolism" title="Paradoxical embolism">Paradoxical embolism</a></li>
</ul>
</li>
<li><a href="/wiki/Thrombosis" title="Thrombosis">Thrombosis</a></li>
<li><a href="/wiki/Vasculitis" title="Vasculitis">Vasculitis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Blood_pressure" title="Blood pressure">Blood pressure</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Hypertension" title="Hypertension">Hypertension</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Hypertensive_heart_disease" title="Hypertensive heart disease">Hypertensive heart disease</a></li>
<li><a href="/wiki/Hypertensive_emergency" title="Hypertensive emergency">Hypertensive emergency</a></li>
<li><a href="/wiki/Hypertensive_nephropathy" title="Hypertensive nephropathy">Hypertensive nephropathy</a></li>
<li><a href="/wiki/Essential_hypertension" title="Essential hypertension">Essential hypertension</a></li>
<li><a href="/wiki/Secondary_hypertension" title="Secondary hypertension">Secondary hypertension</a>
<ul>
<li><a href="/wiki/Renovascular_hypertension" title="Renovascular hypertension">Renovascular hypertension</a></li>
</ul>
</li>
<li><a href="/wiki/Benign_hypertension" title="Benign hypertension">Benign hypertension</a></li>
<li><a href="/wiki/Pulmonary_hypertension" title="Pulmonary hypertension">Pulmonary hypertension</a></li>
<li><a href="/wiki/Systolic_hypertension" title="Systolic hypertension">Systolic hypertension</a></li>
<li><a href="/wiki/White_coat_hypertension" title="White coat hypertension">White coat hypertension</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Hypotension" title="Hypotension">Hypotension</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Orthostatic_hypotension" title="Orthostatic hypotension">Orthostatic hypotension</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Vascular_navs" title="Template:Vascular navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Vascular_navs" title="Template talk:Vascular navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Vascular_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of the <a href="/wiki/Circulatory_system" title="Circulatory system">circulatory system</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Arteries_and_veins" title="Template:Arteries and veins">Anatomy</a></li>
<li>Arteries
<ul>
<li><a href="/wiki/Template:Arteries_of_head_and_neck" title="Template:Arteries of head and neck">head and neck</a></li>
<li><a href="/wiki/Template:Arteries_of_upper_limbs" title="Template:Arteries of upper limbs">arms</a></li>
<li><a href="/wiki/Template:Arteries_of_thorax" title="Template:Arteries of thorax">chest</a></li>
<li><a href="/wiki/Template:Arteries_of_abdomen" title="Template:Arteries of abdomen">abdomen</a></li>
<li><a href="/wiki/Template:Arteries_of_lower_limbs" title="Template:Arteries of lower limbs">legs</a></li>
</ul>
</li>
<li>Veins
<ul>
<li><a href="/wiki/Template:Veins_of_the_head_and_neck" title="Template:Veins of the head and neck">head and neck</a></li>
<li><a href="/wiki/Template:Veins_of_the_upper_limb" title="Template:Veins of the upper limb">arms</a></li>
<li><a href="/wiki/Template:Veins_of_the_thorax_and_vertebral_column" title="Template:Veins of the thorax and vertebral column">chest</a></li>
<li><a href="/wiki/Template:Veins_of_the_abdomen_and_pelvis" title="Template:Veins of the abdomen and pelvis">abdomen and pelvis</a></li>
<li><a href="/wiki/Template:Veins_of_the_lower_limb" title="Template:Veins of the lower limb">legs</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Development_of_mammalian_circulatory_system" title="Template:Development of mammalian circulatory system">Development</a></li>
<li><a href="/wiki/Template:Human_cell_types_derived_primarily_from_mesoderm" title="Template:Human cell types derived primarily from mesoderm">Cells</a></li>
<li><a href="/wiki/Template:Cardiovascular_physiology" title="Template:Cardiovascular physiology">Physiology</a>
<ul>
<li><a href="/wiki/Template:Angiogenic_proteins" title="Template:Angiogenic proteins">proteins</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Congenital_vascular_defects" title="Template:Congenital vascular defects">Congenital</a></li>
<li><a href="/wiki/Template:Vascular_tumors" title="Template:Vascular tumors">Neoplasms and cancer</a></li>
<li><a href="/wiki/Template:Lymphatic_vessel_disease" title="Template:Lymphatic vessel disease">Lymphatic vessels</a></li>
<li><a href="/wiki/Template:Chest_trauma" title="Template:Chest trauma">Injury</a></li>
<li><a href="/wiki/Template:Systemic_vasculitis" title="Template:Systemic vasculitis">Vasculitis</a></li>
<li><a href="/wiki/Template:Vascular_diseases" title="Template:Vascular diseases">Other</a></li>
<li><a href="/wiki/Template:Cardiovascular_system_symptoms_and_signs" title="Template:Cardiovascular system symptoms and signs">Symptoms and signs</a>
<ul>
<li><a href="/wiki/Template:Eponymous_medical_signs_for_cardiovascular_system" title="Template:Eponymous medical signs for cardiovascular system">eponymous</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Vascular_procedures" title="Template:Vascular procedures">Procedures</a></li>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Beta_blockers" title="Template:Beta blockers">beta blockers</a></li>
<li><a href="/wiki/Template:Channelergics" title="Template:Channelergics" class="mw-redirect">channel blockers</a></li>
<li><a href="/wiki/Template:Diuretics" title="Template:Diuretics">diuretics</a></li>
<li><a href="/wiki/Template:Nonsympatholytic_vasodilatory_antihypertensives" title="Template:Nonsympatholytic vasodilatory antihypertensives">nonsympatholytic vasodilatory antihypertensives</a></li>
<li><a href="/wiki/Template:Peripheral_vasodilators" title="Template:Peripheral vasodilators">peripheral vasodilators</a></li>
<li><a href="/wiki/Template:Agents_acting_on_the_renin-angiotensin_system" title="Template:Agents acting on the renin-angiotensin system">renin–angiotensin system</a></li>
<li><a href="/wiki/Template:Sympatholytic_antihypertensives" title="Template:Sympatholytic antihypertensives">sympatholytic antihypertensives</a></li>
<li><a href="/wiki/Template:Vasoprotectives" title="Template:Vasoprotectives">vasoprotectives</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks hlist collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Cell_surface_receptor_deficiencies" title="Template:Cell surface receptor deficiencies"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Cell_surface_receptor_deficiencies" title="Template talk:Cell surface receptor deficiencies"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cell_surface_receptor_deficiencies&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Cell_surface_receptor" title="Cell surface receptor">Cell surface receptor</a> deficiencies</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/G_protein-coupled_receptor" title="G protein-coupled receptor" class="mw-redirect">G protein-coupled receptor</a><br />
(including <a href="/wiki/Hormone_receptor" title="Hormone receptor">hormone</a>)</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group">Class A</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Thyrotropin_receptor" title="Thyrotropin receptor">TSHR</a></i> (<a href="/wiki/Congenital_hypothyroidism" title="Congenital hypothyroidism">Congenital hypothyroidism 1</a>)</li>
<li><i><a href="/wiki/Luteinizing_hormone/choriogonadotropin_receptor" title="Luteinizing hormone/choriogonadotropin receptor">LHCGR</a></i> (<a href="/wiki/Luteinizing_hormone_insensitivity" title="Luteinizing hormone insensitivity" class="mw-redirect">Luteinizing hormone insensitivity</a>, <a href="/wiki/Leydig_cell_hypoplasia" title="Leydig cell hypoplasia">Leydig cell hypoplasia</a>, <a href="/wiki/Male-limited_precocious_puberty" title="Male-limited precocious puberty" class="mw-redirect">Male-limited precocious puberty</a>)</li>
<li><i><a href="/wiki/FSH-receptor" title="FSH-receptor" class="mw-redirect">FSHR</a></i> (<a href="/wiki/Follicle-stimulating_hormone_insensitivity" title="Follicle-stimulating hormone insensitivity">Follicle-stimulating hormone insensitivity</a>, <a href="/wiki/XX_gonadal_dysgenesis" title="XX gonadal dysgenesis">XX gonadal dysgenesis</a>)</li>
<li><i><a href="/wiki/Gonadotropin-releasing_hormone_receptor" title="Gonadotropin-releasing hormone receptor">GnRHR</a></i> (<a href="/wiki/Gonadotropin-releasing_hormone_insensitivity" title="Gonadotropin-releasing hormone insensitivity">Gonadotropin-releasing hormone insensitivity</a>)</li>
<li><i><a href="/wiki/Endothelin_receptor" title="Endothelin receptor">EDNRB</a></i> (<a href="/wiki/ABCD_syndrome" title="ABCD syndrome">ABCD syndrome</a>, <a href="/wiki/Waardenburg_syndrome" title="Waardenburg syndrome">Waardenburg syndrome 4a</a>, <a href="/wiki/Hirschsprung%27s_disease" title="Hirschsprung's disease">Hirschsprung's disease 2</a>)</li>
<li><i><a href="/wiki/AVPR2" title="AVPR2" class="mw-redirect">AVPR2</a></i> (<a href="/wiki/Nephrogenic_diabetes_insipidus" title="Nephrogenic diabetes insipidus">Nephrogenic diabetes insipidus 1</a>)</li>
<li><i><a href="/wiki/Prostaglandin_E2_receptor" title="Prostaglandin E2 receptor">PTGER2</a></i> (<a href="/wiki/Aspirin-induced_asthma" title="Aspirin-induced asthma">Aspirin-induced asthma</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Class B</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/PTH1R" title="PTH1R" class="mw-redirect">PTH1R</a></i> (<a href="/wiki/Jansen%27s_metaphyseal_chondrodysplasia" title="Jansen's metaphyseal chondrodysplasia">Jansen's metaphyseal chondrodysplasia</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Class C</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Calcium-sensing_receptor" title="Calcium-sensing receptor">CASR</a></i> (<a href="/wiki/Familial_hypocalciuric_hypercalcemia" title="Familial hypocalciuric hypercalcemia">Familial hypocalciuric hypercalcemia</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Class F</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/FZD4" title="FZD4">FZD4</a></i> (<a href="/wiki/Familial_exudative_vitreoretinopathy" title="Familial exudative vitreoretinopathy">Familial exudative vitreoretinopathy 1</a>)</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Enzyme-linked_receptor" title="Enzyme-linked receptor">Enzyme-linked receptor</a><br />
(including<br />
<a href="/wiki/Growth_factor_receptor" title="Growth factor receptor">growth factor</a>)</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Receptor_tyrosine_kinase" title="Receptor tyrosine kinase">RTK</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/ROR2" title="ROR2">ROR2</a></i> (<a href="/wiki/Robinow_syndrome" title="Robinow syndrome">Robinow syndrome</a>)</li>
<li><i><a href="/wiki/Fibroblast_growth_factor_receptor_1" title="Fibroblast growth factor receptor 1">FGFR1</a></i> (<a href="/wiki/Pfeiffer_syndrome" title="Pfeiffer syndrome">Pfeiffer syndrome</a>, <a href="/wiki/Kallmann_syndrome" title="Kallmann syndrome">KAL2 Kallmann syndrome</a>)</li>
<li><i><a href="/wiki/Fibroblast_growth_factor_receptor_2" title="Fibroblast growth factor receptor 2">FGFR2</a></i> (<a href="/wiki/Apert_syndrome" title="Apert syndrome">Apert syndrome</a>, <a href="/wiki/Antley%E2%80%93Bixler_syndrome" title="Antley–Bixler syndrome">Antley–Bixler syndrome</a>, <a href="/wiki/Pfeiffer_syndrome" title="Pfeiffer syndrome">Pfeiffer syndrome</a>, <a href="/wiki/Crouzon_syndrome" title="Crouzon syndrome">Crouzon syndrome</a>, <a href="/wiki/Jackson%E2%80%93Weiss_syndrome" title="Jackson–Weiss syndrome">Jackson–Weiss syndrome</a>)</li>
<li><i><a href="/wiki/Fibroblast_growth_factor_receptor_3" title="Fibroblast growth factor receptor 3">FGFR3</a></i> (<a href="/wiki/Achondroplasia" title="Achondroplasia">Achondroplasia</a>, <a href="/wiki/Hypochondroplasia" title="Hypochondroplasia">Hypochondroplasia</a>, <a href="/wiki/Thanatophoric_dysplasia" title="Thanatophoric dysplasia">Thanatophoric dysplasia</a>, <a href="/wiki/Muenke_syndrome" title="Muenke syndrome">Muenke syndrome</a>)</li>
<li><i><a href="/wiki/Insulin_receptor" title="Insulin receptor">INSR</a></i> (<a href="/wiki/Donohue_syndrome" title="Donohue syndrome">Donohue syndrome</a></li>
<li><a href="/wiki/Rabson%E2%80%93Mendenhall_syndrome" title="Rabson–Mendenhall syndrome">Rabson–Mendenhall syndrome</a>)</li>
<li><i><a href="/wiki/TrkA_receptor" title="TrkA receptor" class="mw-redirect">NTRK1</a></i> (<a href="/wiki/Congenital_insensitivity_to_pain_with_anhidrosis" title="Congenital insensitivity to pain with anhidrosis">Congenital insensitivity to pain with anhidrosis</a>)</li>
<li><i><a href="/wiki/CD117" title="CD117">KIT</a></i> (<a href="/wiki/Piebaldism" title="Piebaldism">KIT Piebaldism</a>, <a href="/wiki/Gastrointestinal_stromal_tumor" title="Gastrointestinal stromal tumor">Gastrointestinal stromal tumor</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Serine/threonine-specific_protein_kinase" title="Serine/threonine-specific protein kinase">STPK</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Anti-M%C3%BCllerian_hormone_receptor" title="Anti-Müllerian hormone receptor">AMHR2</a></i> (<a href="/wiki/Persistent_M%C3%BCllerian_duct_syndrome" title="Persistent Müllerian duct syndrome">Persistent Müllerian duct syndrome II</a>)</li>
</ul>
<ul>
<li><a href="/wiki/TGF_beta_receptors" title="TGF beta receptors">TGF beta receptors</a>: <a href="/wiki/Endoglin" title="Endoglin">Endoglin</a>/<a href="/wiki/ACVRL1" title="ACVRL1">Alk-1</a>/<a href="/wiki/Mothers_against_decapentaplegic_homolog_4" title="Mothers against decapentaplegic homolog 4">SMAD4</a> (<strong class="selflink">Hereditary hemorrhagic telangiectasia</strong>)</li>
<li><a href="/wiki/TGF_beta_receptor_1" title="TGF beta receptor 1">TGFBR1</a>/<a href="/wiki/TGF_beta_receptor_2" title="TGF beta receptor 2">TGFBR2</a> (<a href="/wiki/Loeys-Dietz_syndrome" title="Loeys-Dietz syndrome" class="mw-redirect">Loeys-Dietz syndrome</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Guanylate_cyclase" title="Guanylate cyclase">GC</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/GUCY2D" title="GUCY2D">GUCY2D</a></i> (<a href="/wiki/Leber%27s_congenital_amaurosis" title="Leber's congenital amaurosis">Leber's congenital amaurosis 1</a>)</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/JAK-STAT_signaling_pathway" title="JAK-STAT signaling pathway">JAK-STAT</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Type_I_cytokine_receptor" title="Type I cytokine receptor">Type I cytokine receptor</a>: <i><a href="/wiki/Growth_hormone_receptor" title="Growth hormone receptor">GH</a></i> (<a href="/wiki/Laron_syndrome" title="Laron syndrome">Laron syndrome</a>)</li>
<li><i><a href="/wiki/Granulocyte_macrophage_colony-stimulating_factor_receptor" title="Granulocyte macrophage colony-stimulating factor receptor">CSF2RA</a></i> (<a href="/wiki/Surfactant_metabolism_dysfunction" title="Surfactant metabolism dysfunction">Surfactant metabolism dysfunction 4</a>)</li>
</ul>
<ul>
<li><a href="/wiki/Myeloproliferative_leukemia_virus_oncogene" title="Myeloproliferative leukemia virus oncogene" class="mw-redirect">MPL</a> (<a href="/wiki/Congenital_amegakaryocytic_thrombocytopenia" title="Congenital amegakaryocytic thrombocytopenia">Congenital amegakaryocytic thrombocytopenia</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Tumor_necrosis_factor_receptor" title="Tumor necrosis factor receptor">TNF receptor</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/TNFRSF1A" title="TNFRSF1A" class="mw-redirect">TNFRSF1A</a></i> (<a href="/wiki/TNF_receptor_associated_periodic_syndrome" title="TNF receptor associated periodic syndrome">TNF receptor associated periodic syndrome</a>)</li>
<li><i><a href="/wiki/TNFRSF13B" title="TNFRSF13B" class="mw-redirect">TNFRSF13B</a></i> (<a href="/wiki/Selective_immunoglobulin_A_deficiency" title="Selective immunoglobulin A deficiency">Selective immunoglobulin A deficiency 2</a>)</li>
<li><i><a href="/wiki/CD40_(protein)" title="CD40 (protein)">TNFRSF5</a></i> (<a href="/wiki/Hyper-IgM_syndrome_type_3" title="Hyper-IgM syndrome type 3">Hyper-IgM syndrome type 3</a>)</li>
<li><i><a href="/wiki/TNFRSF13C" title="TNFRSF13C" class="mw-redirect">TNFRSF13C</a></i> (<a href="/wiki/Common_variable_immunodeficiency" title="Common variable immunodeficiency">CVID4</a>)</li>
<li><i><a href="/wiki/TNFRSF13B" title="TNFRSF13B" class="mw-redirect">TNFRSF13B</a></i> (<a href="/wiki/Common_variable_immunodeficiency" title="Common variable immunodeficiency">CVID2</a>)</li>
<li><i><a href="/wiki/Fas_receptor" title="Fas receptor">TNFRSF6</a></i> (<a href="/wiki/Autoimmune_lymphoproliferative_syndrome" title="Autoimmune lymphoproliferative syndrome">Autoimmune lymphoproliferative syndrome 1A</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Lipid receptor</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Lipoprotein_receptor-related_protein" title="Lipoprotein receptor-related protein">LRP</a>: <i><a href="/wiki/LRP2" title="LRP2">LRP2</a></i> (<a href="/wiki/Donnai%E2%80%93Barrow_syndrome" title="Donnai–Barrow syndrome">Donnai–Barrow syndrome</a>)</li>
<li><i><a href="/wiki/Low_density_lipoprotein_receptor-related_protein_4" title="Low density lipoprotein receptor-related protein 4" class="mw-redirect">LRP4</a></i> (<a href="/wiki/Cenani%E2%80%93Lenz_syndactylism" title="Cenani–Lenz syndactylism">Cenani–Lenz syndactylism</a>)</li>
<li><i><a href="/wiki/LRP5" title="LRP5">LRP5</a></i> (<a href="/wiki/Worth_syndrome" title="Worth syndrome">Worth syndrome</a>, <a href="/wiki/Familial_exudative_vitreoretinopathy" title="Familial exudative vitreoretinopathy">Familial exudative vitreoretinopathy 4</a>, <a href="/wiki/Osteopetrosis" title="Osteopetrosis">Osteopetrosis 1</a>)</li>
</ul>
<ul>
<li><i><a href="/wiki/LDL_receptor" title="LDL receptor">LDLR</a></i> (<a href="/wiki/Familial_hypercholesterolemia" title="Familial hypercholesterolemia">LDLR Familial hypercholesterolemia</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other/ungrouped</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Immunoglobulin_superfamily" title="Immunoglobulin superfamily">Immunoglobulin superfamily</a>: <a href="/wiki/Hypogammaglobulinemia" title="Hypogammaglobulinemia">AGM3, 6</a></li>
</ul>
<ul>
<li><a href="/wiki/Integrin" title="Integrin">Integrin</a>: <a href="/wiki/Leukocyte_adhesion_deficiency-1" title="Leukocyte adhesion deficiency-1">LAD1</a></li>
<li><a href="/wiki/Glanzmann%27s_thrombasthenia" title="Glanzmann's thrombasthenia">Glanzmann's thrombasthenia</a></li>
<li><a href="/wiki/Junctional_epidermolysis_bullosa_with_pyloric_atresia" title="Junctional epidermolysis bullosa with pyloric atresia" class="mw-redirect">Junctional epidermolysis bullosa with pyloric atresia</a></li>
</ul>
<p><i><a href="/wiki/EDAR" title="EDAR" class="mw-redirect">EDAR</a></i> (<a href="/wiki/Hypohidrotic_ectodermal_dysplasia" title="Hypohidrotic ectodermal dysplasia">EDAR hypohidrotic ectodermal dysplasia</a>)</p>
<ul>
<li><i><a href="/wiki/PTCH1" title="PTCH1">PTCH1</a></i> (<a href="/wiki/Nevoid_basal-cell_carcinoma_syndrome" title="Nevoid basal-cell carcinoma syndrome">Nevoid basal-cell carcinoma syndrome</a>)</li>
<li><i><a href="/wiki/BMPR1A" title="BMPR1A">BMPR1A</a></i> (<a href="/wiki/Juvenile_polyposis_syndrome" title="Juvenile polyposis syndrome">BMPR1A juvenile polyposis syndrome</a>)</li>
<li><i><a href="/wiki/IL2RG" title="IL2RG" class="mw-redirect">IL2RG</a></i> (<a href="/wiki/X-linked_severe_combined_immunodeficiency" title="X-linked severe combined immunodeficiency">X-linked severe combined immunodeficiency</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2">
<div>
<dl>
<dt>See also</dt>
<dd><a href="/wiki/Template:Cell_surface_receptors" title="Template:Cell surface receptors">cell surface receptors</a><br /></dd>
</dl>
</div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Cell_navs" title="Template:Cell navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Cell_navs" title="Template talk:Cell navs" class="mw-redirect"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cell_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of cells</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Cellular_structures" title="Template:Cellular structures">Structure</a>
<ul>
<li><a href="/wiki/Template:Nucleus" title="Template:Nucleus">nucleus</a>
<ul>
<li><a href="/wiki/Template:Chromosome_genetics" title="Template:Chromosome genetics"><i>chromosome genetics</i></a></li>
</ul>
</li>
</ul>
</li>
<li>Organelles
<ul>
<li><a href="/wiki/Template:Peroxisomal_proteins" title="Template:Peroxisomal proteins">peroxisome</a></li>
<li><a href="/wiki/Template:Cytoskeletal_proteins" title="Template:Cytoskeletal proteins">cytoskeleton</a></li>
<li><a href="/wiki/Template:Centrosome" title="Template:Centrosome">centrosome</a></li>
<li><a href="/wiki/Template:Epithelial_proteins" title="Template:Epithelial proteins">epithelia</a></li>
<li><a href="/wiki/Template:Ciliary_proteins" title="Template:Ciliary proteins">cilia</a></li>
<li><a href="/wiki/Template:Mitochondrial_proteins" title="Template:Mitochondrial proteins">mitochondria</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Cell_membranes" title="Template:Cell membranes">Membranes</a>
<ul>
<li><a href="/wiki/Template:Cell_membrane_proteins" title="Template:Cell membrane proteins" class="mw-redirect">proteins</a></li>
<li><a href="/wiki/Template:Cell_adhesion_molecules" title="Template:Cell adhesion molecules">cell adhesions</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Membrane_transport" title="Template:Membrane transport">Membrane transport</a>
<ul>
<li><a href="/wiki/Template:Ion_channels" title="Template:Ion channels">ion channels</a></li>
<li><a href="/wiki/Template:Vesicular_transport_proteins" title="Template:Vesicular transport proteins">vesicular transport</a></li>
<li><a href="/wiki/Template:Solute_carrier_family" title="Template:Solute carrier family">solute carrier</a></li>
<li><a href="/wiki/Template:ABC_transporters" title="Template:ABC transporters">ABC transporters</a></li>
<li><a href="/wiki/Template:ATPase" title="Template:ATPase">ATPase</a></li>
<li><a href="/wiki/Template:Oxidoreduction-driven_transporters" title="Template:Oxidoreduction-driven transporters">oxidoreduction-driven</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li>Structural
<ul>
<li><a href="/wiki/Template:Peroxisomal_disorders" title="Template:Peroxisomal disorders">peroxisome</a></li>
<li><a href="/wiki/Template:Cytoskeletal_defects" title="Template:Cytoskeletal defects">cytoskeleton</a></li>
<li><a href="/wiki/Template:Ciliopathy" title="Template:Ciliopathy">cilia</a></li>
<li><a href="/wiki/Template:Mitochondrial_diseases" title="Template:Mitochondrial diseases">mitochondria</a></li>
<li><a href="/wiki/Template:Nucleus_diseases" title="Template:Nucleus diseases">nucleus</a></li>
<li><a href="/wiki/Template:Scleroprotein_disease" title="Template:Scleroprotein disease">scleroprotein</a></li>
</ul>
</li>
<li>Membrane
<ul>
<li><a href="/wiki/Template:Channelopathy" title="Template:Channelopathy">channelopathy</a></li>
<li><a href="/wiki/Template:Solute_carrier_disorders" title="Template:Solute carrier disorders">solute carrier</a></li>
<li><a href="/wiki/Template:ATPase_disorders" title="Template:ATPase disorders">ATPase</a></li>
<li><a href="/wiki/Template:ABC_transporter_disorders" title="Template:ABC transporter disorders">ABC transporters</a></li>
<li><a href="/wiki/Template:Other_cell_membrane_protein_disorders" title="Template:Other cell membrane protein disorders">other</a></li>
<li><a href="/wiki/Template:Extracellular_ligand_disorders" title="Template:Extracellular ligand disorders">extracellular ligands</a></li>
<li><a href="/wiki/Template:Cell_surface_receptor_deficiencies" title="Template:Cell surface receptor deficiencies">cell surface receptors</a></li>
<li><a href="/wiki/Template:Deficiencies_of_intracellular_signaling_peptides_and_proteins" title="Template:Deficiencies of intracellular signaling peptides and proteins">intracellular signalling</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Vesicular_transport_protein_disorders" title="Template:Vesicular transport protein disorders">Vesicular transport</a></li>
<li><a href="/wiki/Template:Pore-forming_toxins" title="Template:Pore-forming toxins">Pore-forming toxins</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1176
CPU time usage: 0.672 seconds
Real time usage: 0.796 seconds
Preprocessor visited node count: 4147/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 191234/2097152 bytes
Template argument size: 1070/2097152 bytes
Highest expansion depth: 10/40
Expensive parser function count: 0/500
Lua time usage: 0.174/10.000 seconds
Lua memory usage: 2.99 MB/50 MB
-->

<!-- 
Transclusion expansion time report (%,ms,calls,template)
100.00%  569.279      1 - -total
 35.46%  201.840      1 - Template:Reflist
 23.16%  131.868     10 - Template:Navbox
 20.60%  117.292     29 - Template:Cite_journal
 16.56%   94.299      1 - Template:Infobox_disease
 14.72%   83.818      1 - Template:Infobox
 11.44%   65.141      1 - Template:Vascular_diseases
 10.74%   61.150      1 - Template:Good_article
 10.35%   58.931      1 - Template:Top_icon
  6.13%   34.891      1 - Template:Receptor_deficiencies
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:728467-0!*!0!!en!4!* and timestamp 20150712003550 and revision id 670374599
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>					<div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Hereditary_hemorrhagic_telangiectasia&amp;oldid=670374599">https://en.wikipedia.org/w/index.php?title=Hereditary_hemorrhagic_telangiectasia&amp;oldid=670374599</a>"					</div>
				<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Diseases_of_arteries,_arterioles_and_capillaries" title="Category:Diseases of arteries, arterioles and capillaries">Diseases of arteries, arterioles and capillaries</a></li><li><a href="/wiki/Category:Vascular-related_cutaneous_conditions" title="Category:Vascular-related cutaneous conditions">Vascular-related cutaneous conditions</a></li><li><a href="/wiki/Category:Respiratory_diseases" title="Category:Respiratory diseases">Respiratory diseases</a></li><li><a href="/wiki/Category:Neurological_disorders" title="Category:Neurological disorders">Neurological disorders</a></li><li><a href="/wiki/Category:Autosomal_dominant_disorders" title="Category:Autosomal dominant disorders">Autosomal dominant disorders</a></li><li><a href="/wiki/Category:Cell_surface_receptor_deficiencies" title="Category:Cell surface receptor deficiencies">Cell surface receptor deficiencies</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">CS1 maint: Explicit use of et al.</a></li><li><a href="/wiki/Category:Articles_with_contributors_link" title="Category:Articles with contributors link">Articles with contributors link</a></li><li><a href="/wiki/Category:Articles_that_use_a_Medicine_navs_subtemplate" title="Category:Articles that use a Medicine navs subtemplate">Articles that use a Medicine navs subtemplate</a></li><li><a href="/wiki/Category:Good_articles" title="Category:Good articles">Good articles</a></li></ul></div></div>				<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>

			<div id="mw-head">
									<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
						<h3 id="p-personal-label">Personal tools</h3>
						<ul>
							<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Hereditary+hemorrhagic+telangiectasia&amp;type=signup" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Hereditary+hemorrhagic+telangiectasia" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>						</ul>
					</div>
									<div id="left-navigation">
										<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
						<h3 id="p-namespaces-label">Namespaces</h3>
						<ul>
															<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Hereditary_hemorrhagic_telangiectasia"  title="View the content page [c]" accesskey="c">Article</a></span></li>
															<li  id="ca-talk"><span><a href="/wiki/Talk:Hereditary_hemorrhagic_telangiectasia"  title="Discussion about the content page [t]" accesskey="t" rel="discussion">Talk</a></span></li>
													</ul>
					</div>
										<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
												<h3 id="p-variants-label">
							<span>Variants</span><a href="#"></a>
						</h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
									</div>
				<div id="right-navigation">
										<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
						<h3 id="p-views-label">Views</h3>
						<ul>
															<li id="ca-view" class="selected"><span><a href="/wiki/Hereditary_hemorrhagic_telangiectasia" >Read</a></span></li>
															<li id="ca-edit"><span><a href="/w/index.php?title=Hereditary_hemorrhagic_telangiectasia&amp;action=edit"  title="Edit this page [e]" accesskey="e">Edit</a></span></li>
															<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Hereditary_hemorrhagic_telangiectasia&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
													</ul>
					</div>
										<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
						<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
										<div id="p-search" role="search">
						<h3>
							<label for="searchInput">Search</label>
						</h3>

						<form action="/w/index.php" id="searchform">
							<div id="simpleSearch">
							<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />							</div>
						</form>
					</div>
									</div>
			</div>
			<div id="mw-panel">
				<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
						<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
			<h3 id='p-navigation-label'>Navigation</h3>

			<div class="body">
									<ul>
						<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikipedia store</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
			<h3 id='p-interaction-label'>Interaction</h3>

			<div class="body">
									<ul>
						<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
			<h3 id='p-tb-label'>Tools</h3>

			<div class="body">
									<ul>
						<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Hereditary_hemorrhagic_telangiectasia" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Hereditary_hemorrhagic_telangiectasia" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Hereditary_hemorrhagic_telangiectasia&amp;oldid=670374599" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Hereditary_hemorrhagic_telangiectasia&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q776881" title="Link to connected data repository item [g]" accesskey="g">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Hereditary_hemorrhagic_telangiectasia&amp;id=670374599" title="Information on how to cite this page">Cite this page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
			<h3 id='p-coll-print_export-label'>Print/export</h3>

			<div class="body">
									<ul>
						<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Hereditary+hemorrhagic+telangiectasia">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Hereditary+hemorrhagic+telangiectasia&amp;oldid=670374599&amp;writer=rdf2latex">Download as PDF</a></li><li id="t-print"><a href="/w/index.php?title=Hereditary_hemorrhagic_telangiectasia&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
			<h3 id='p-lang-label'>Languages</h3>

			<div class="body">
									<ul>
						<li class="interlanguage-link interwiki-da"><a href="//da.wikipedia.org/wiki/Heredit%C3%A6r_teleangiektasi" title="Hereditær teleangiektasi – Danish" lang="da" hreflang="da">Dansk</a></li><li class="interlanguage-link interwiki-de"><a href="//de.wikipedia.org/wiki/Morbus_Osler" title="Morbus Osler – German" lang="de" hreflang="de">Deutsch</a></li><li class="interlanguage-link interwiki-es"><a href="//es.wikipedia.org/wiki/Enfermedad_de_Rendu-Osler-Weber" title="Enfermedad de Rendu-Osler-Weber – Spanish" lang="es" hreflang="es">Español</a></li><li class="interlanguage-link interwiki-fa"><a href="//fa.wikipedia.org/wiki/%D8%B3%D9%86%D8%AF%D8%B1%D9%85_%D8%A7%D8%B3%D9%84%D8%B1_%D9%88%D8%A8%D8%B1_%D8%B1%D8%A7%D9%86%D8%AF%D9%88" title="سندرم اسلر وبر راندو – Persian" lang="fa" hreflang="fa">فارسی</a></li><li class="interlanguage-link interwiki-fr"><a href="//fr.wikipedia.org/wiki/Maladie_de_Rendu-Osler" title="Maladie de Rendu-Osler – French" lang="fr" hreflang="fr">Français</a></li><li class="interlanguage-link interwiki-it"><a href="//it.wikipedia.org/wiki/Teleangectasia_emorragica_ereditaria" title="Teleangectasia emorragica ereditaria – Italian" lang="it" hreflang="it">Italiano</a></li><li class="interlanguage-link interwiki-nl"><a href="//nl.wikipedia.org/wiki/Ziekte_van_Rendu-Osler-Weber" title="Ziekte van Rendu-Osler-Weber – Dutch" lang="nl" hreflang="nl">Nederlands</a></li><li class="interlanguage-link interwiki-ja"><a href="//ja.wikipedia.org/wiki/%E3%82%AA%E3%82%B9%E3%83%A9%E3%83%BC%E3%83%BB%E3%82%A6%E3%82%A7%E3%83%BC%E3%83%90%E3%83%BC%E3%83%BB%E3%83%A9%E3%83%B3%E3%83%87%E3%83%A5%E7%97%85" title="オスラー・ウェーバー・ランデュ病 – Japanese" lang="ja" hreflang="ja">日本語</a></li><li class="interlanguage-link interwiki-pl"><a href="//pl.wikipedia.org/wiki/Choroba_Rendu-Oslera-Webera" title="Choroba Rendu-Oslera-Webera – Polish" lang="pl" hreflang="pl">Polski</a></li><li class="interlanguage-link interwiki-pt"><a href="//pt.wikipedia.org/wiki/Telangiectasia_hemorr%C3%A1gica_heredit%C3%A1ria" title="Telangiectasia hemorrágica hereditária – Portuguese" lang="pt" hreflang="pt">Português</a></li><li class="interlanguage-link interwiki-ru"><a href="//ru.wikipedia.org/wiki/%D0%91%D0%BE%D0%BB%D0%B5%D0%B7%D0%BD%D1%8C_%D0%A0%D0%B0%D0%BD%D0%B4%D1%8E_%E2%80%94_%D0%9E%D1%81%D0%BB%D0%B5%D1%80%D0%B0" title="Болезнь Рандю — Ослера – Russian" lang="ru" hreflang="ru">Русский</a></li><li class="interlanguage-link interwiki-fi"><a href="//fi.wikipedia.org/wiki/Osler-Weber-Rendu" title="Osler-Weber-Rendu – Finnish" lang="fi" hreflang="fi">Suomi</a></li><li class="interlanguage-link interwiki-uk"><a href="//uk.wikipedia.org/wiki/%D0%A5%D0%B2%D0%BE%D1%80%D0%BE%D0%B1%D0%B0_%D0%A0%D0%B0%D0%BD%D0%B4%D1%8E_%E2%80%94_%D0%9E%D1%81%D0%BB%D0%B5%D1%80%D0%B0" title="Хвороба Рандю — Ослера – Ukrainian" lang="uk" hreflang="uk">Українська</a></li><li class="interlanguage-link interwiki-zh"><a href="//zh.wikipedia.org/wiki/%E9%81%BA%E5%82%B3%E6%80%A7%E5%87%BA%E8%A1%80%E6%80%A7%E8%A1%80%E7%AE%A1%E6%93%B4%E5%BC%B5%E7%97%87" title="遺傳性出血性血管擴張症 – Chinese" lang="zh" hreflang="zh">中文</a></li><li class="uls-p-lang-dummy"><a href="#"></a></li>					</ul>
				<div class='after-portlet after-portlet-lang'><span class="wb-langlinks-edit wb-langlinks-link"><a href="//www.wikidata.org/wiki/Q776881#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>			</div>
		</div>
				</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 7 July 2015, at 15:40.</li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Hereditary_hemorrhagic_telangiectasia&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
											<li id="footer-copyrightico">
							<a href="//wikimediafoundation.org/"><img src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation"/></a>						</li>
											<li id="footer-poweredbyico">
							<a href="//www.mediawiki.org/"><img src="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_132x47.png 1.5x, //en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" /></a>						</li>
									</ul>
						<div style="clear:both"></div>
		</div>
		<script>if(window.jQuery)jQuery.ready();</script><script>if(window.mw){
mw.loader.state({"ext.globalCssJs.site":"ready","ext.globalCssJs.user":"ready","site":"loading","user":"ready","user.groups":"ready"});
}</script>
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.cite.styles%7Cext.gadget.DRN-wizard%2CReferenceTooltips%2CWatchlistGreenIndicators%2Ccharinsert%2Cfeatured-articles-links%2CrefToolbar%2Cswitcher%2Cteahouse%7Cext.wikimediaBadges&amp;only=styles&amp;skin=vector&amp;*" />
<script>if(window.mw){
mw.loader.load(["ext.cite.a11y","mediawiki.toc","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.cirrusSearch.loggingSchema","mmv.bootstrap.autostart","ext.imageMetrics.loader","ext.eventLogging.subscriber","ext.wikimediaEvents","ext.wikimediaEvents.statsd","ext.navigationTiming","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.WatchlistGreenIndicators","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.switcher","ext.gadget.featured-articles-links","ext.visualEditor.targetLoader","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage"],null,true);
}</script>
<script>if(window.mw){
document.write("\u003Cscript src=\"//en.wikipedia.org/w/load.php?debug=false\u0026amp;lang=en\u0026amp;modules=site\u0026amp;only=scripts\u0026amp;skin=vector\u0026amp;*\"\u003E\u003C/script\u003E");
}</script>
<script>if(window.mw){
mw.config.set({"wgBackendResponseTime":89,"wgHostname":"mw1217"});
}</script>
	</body>
</html>
